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behorende bij het proefschrift: 
NOVEL POLYCAPROLACTONE-TRICALCIUM PHOSPHATE 
(PCL-TCP) SCAFFOLDS CUSTOMIZED FOR RECONSTRUCTION OF 
DENTOALVEOLAR DEFORMITIES 
Alvin Boon Keng Yeo 
Groningen, 24 maart 2010 
1. The rate of bone formation is dependent on the degradation rates of the 
bone grafting materials utilized. (This thesis) 
2. Throughout the phases of degradation, PCL-TCP scaffolds maintained 
their pore interconnectivity as they became more porous. (This thesis) 
3. Selective modification using sodium hydroxide demonstrates a simple 
approach for tailoring the physical properties and degradation rate of 
PCL-TCP scaffolds. (This thesis) 
4. Pretreatment of PCL-TCP scaffolds with sodium hydroxide increases the 
hydrophilicity and overall surface area for initial matrix deposition and 
early bone ingrowth. (This thesis) 
5. During the early phases of healing, greater bone formation and superior 
mechanical properties can be expected from PCL-TCP scaffolds with 
increased surface roughness. (This thesis) 
6. Laughter is the best medicine. (Author Unknown) 
7. Our greatest glory is not in never falling but in rising every time we fall. 
(Confucius) 
8. People with goals succeed because they know where they are going. 
( Earl Nightingale) 
9. Genius is one percent inspiration and ninety-nine percent pe�rtffttteli½,----­
(Thomas Edison) 
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Defect grafted with autograft after 2 weeks. Woven 41 
bone (W) is seen almost to the level of the expanded 
polytetrafluoroethylene membrane (Mm). Cancellous part 
of the mandible (C). Compact part of the mandible (Co). 
Undecalcified ground section stained with toluidine blue. 
Defect grafted with HA after 2 weeks. HA particles (HA) 42 
with smooth surfaces (arrows) embedded in a dense cell-
rich connective tissue (CT). Undecalcified ground section 
stained with toluidine blue. HA, hydroxyapatite 
Defect grafted with TCP after 2 weeks. TCP particles 42 
(T) demonstrating an irregular surface (thick arrows) 
surrounded by a dense cell-rich connective tissue (C) 
containing small fragments of TCP (thin arrows). 
Undecalcified ground section stained with toluidine blue. 
TCP, P-tricalciumphosphate 
Defect grafted with TCP after 4 weeks. The formation of 43 
woven bone (W) is mainly observed in between the TCP 
particles (T). Only a few contact zones can be identified (*). 







Defect grafted with HAffCP after 4 weeks. The HArrCP 44 
particles (HA/fCP) are embedded in woven bone and a dense 
connective tissue (C). Multi-nucleated giant cells can be 
identified on the surfaces of the HA /fCP particles (arrows). 
Undecalcified ground section stained with toluidine blue. 
HA, hydroxyapatite; TCP, P-tricalciumphosphate. 
Defect grafted with TCP after 8 weeks. A few remnants 45 
of the TCP particles (arrows) can be identified, completely 
integrated in bone. The newly formed bone is predominantly 
woven bone (W) reinforced with parallel-fibered bone (P). 
A mature bone marrow is developing (M). Undecalcified 
ground section stained with toluidine blue. TCP, 
P-tricalciumphosphate. 
TRAP staining of undecalcified ground section. Defect 45 
grafted with HA/fCP after 8 weeks. TRAP positive 
multinucleated giant cells (arrows) can be observed on 
the HA/fCP surfaces (HA/fCP). Woven bone is seen in 
between the particles (W). HA, hydroxyapatite; TCP, 
P-tricalciumphosphate; TRAP, tartrateresistant acid 
phosphatase. 
Defect grafted with HArrCP after 8 weeks. The HA/ 46 
TCP particles (HArrCP) are predominantly integrated in 
woven bone (W). Parallel-fibered bone (P) is seen in a few 
areas. On the surface heading the developing bone marrow 
(M), multiple multi-nucleated giant cells can be identified 
(black arrows). A stained surface zone (white arrows) 
can consistently be observed on the HAffCP particles. 
Undecalcified ground section stained with toluidine blue. 
HA, hydroxyapatite; TCP, P-tricalciumphosphate. 
Defect grafted with HA after 24 weeks. The HA particles 47 
(HA) are completely integrated in woven bone (W), parallel­
fibered bone (P), and lamellar bone (L). The surfaces of the 
HA particles (HA) appear more irregular compared with 
earlier time points (arrows). Undecalcified ground section 
stained with toluidine blue. HA, hydroxyapatite. 
Figure JO Defect grafted with HA/TCP after 24 weeks. The HA/TCP 47 
particles (HA/TCP) are completely integrated in woven 
bone (W), parallel-fibered bone (P), and Iamellar bone 
(L). A stained surface zone (arrows) can consistently be 
observed on the HA/TCP particles. Undecalcified ground 
section stained with toluidine blue. HA, hydroxyapatite; 
TCP, �-tricalciumphosphate. 
Figure 11 Histomorphometric evaluation of the mean volume fractions 49 
of bone, grafting material, and soft tissue occupying the 
defects. 
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PCL-TCP scaffold specimen measuring 6mm in diameter 104 
and 2mm in thickness 
Implanted scaffolds within the assigned defects in the 106 
calvaria of a rabbit 
SEM images of PCL-TCP scaffolds of different NaOH 108 
treatment groups with TCPparticles encircled(A) Untreated. 
(B) 3M NaOH treated/ 48 hr. Appearance of numerous pits 
and indentations can be observed on the scaffold rods. (C) 
3M NaOH treated/ 96 hr. Appearance of numerous pits and 
indentations can be observed on the scaffold rods 
Cross-sectional representation of a PCL-TCP scaffold 109 
rod before and after NaOH treatment. (A) Untreated. 
Appearance of evenly distributed 'bumps' of TCP particles 
is illustrated. (B) 3M NaOH treated (48 and 96 hr). 
Appearance of multiple 'channel-like' pits is illustrated. 
Micro-CT images of PCL-TCP scaffolds of different NaOH 1 JO 
treatment groups. The uniformly distributed white specks 
on the scaffold rods represent TCP particles. (A) Untreated. 
(B) 3M NaOH treated/ 48 hr. (C) 3M NaOH treated/ 96 hr 
Figure 5 Mean rod thickness and mean pore separation of different 111 
NaOH treatment groups 
Figure 6 SEM images of PCL-TCP scaffolds showing their respective 111 
contact angles of different NaOH treatment groups. (A) 
Untreated. (B) 3M NaOH treated/ 48 hr. (C) 3M NaOH 
treated/ 96 hr 
Figure 7 Water contact angle measurements of different NaOH 1 12  
treatment groups. Data are shown as mean ± SD. (*) 
indicates statistical significant mean water contact angle (p 
< 0.05) between untreated and NaOH treated scaffolds. 
Figure 8a SEM images of untreated PCL-TCP scaffold specimens. 1 12  
(A) 25X magnification. (B) I O0X magnification 
Figure 8b SEM images of PCL-TCP scaffold specimens of different 113 
NaOH treatment groups after 2 weeks of implantation. 
(A) Untreated. (B) 3M NaOH treated/ 48 hr. (C) 3M NaOH 
treated/ 96 hr 
Figure 8c SEM images of PCL-TCP scaffold specimens of different 1 14  
NaOH treatment groups after 4 weeks of implantation. (A) 
Untreated. (B) 3M NaOH treated/48 hr. (C) 3M NaOH 
treated/ 96 hr 
Figure 8d SEM images of PCL-TCP scaffold specimens of different 1 14  
NaOH treatment groups after 8 weeks of implantation. (A) 
Untreated. (B) 3M NaOH treated/48 hr. (C) 3M NaOH 
treated/ 96 hr 
Figure 9 Resultant new bone volume detected from defect sites of 1 15 
different NaOH treatment groups using Micro-CT analyses 
after 2, 4 and 8 weeks of implantation. Data are shown as 
mean ± SD. (t) indicates statistical significant mean new 
bone volume (p < 0. 1) between untreated and Na OH treated 
scaffolds at 8 weeks. 
CHAPTER 6 Surface modification of PCL-TCP scaffolds in rabbit 
calvaria defects: Evaluation of scaffold degradation 










SEM images of PCL-TCP scaffolds treated with NaOH for 127 
(A) 0 hours (B) 48 hours (C) 96 hours 
Schematic drawing of specimen undergoing push out test 128 
Gross photographs of the rabbit calvaria (A) 12  weeks. 130 
(B) 24 weeks following implantation of the scaffolds in 
the defects. The scaffolds were fully integrated into the 
surrounding host bone devoid of any fibrous encapsulation 
or foreign body reaction. Blood vessels formation were 
observed within all the reconstructed scaffolds 
Compressive strength of PCL-TCP scaffolds under different 131 
NaOH treatment exposures over time. Data are shown as 
mean ± SD 
Push out test of PCL-TCP scaffolds under different NaOH 132 
treatment exposures over time. Data are shown as mean ± 
SD 
Resultant PCL-TCP scaffold volume under different NaOH 133 
treatment exposures over time. Data are shown as mean ± 
SD 
Percentage of PCL-TCP scaffold volume loss under 133 
different NaOH treatment exposures over time. Data are 
shown as mean ± SD 
New bone formation within PCL-TCP scaffolds under 134 
different NaOH treatment exposures over time. Data are 
shown as mean ± SD. (*) Indicates statistical significant 
mean bone volume detected (p < 0.05) between untreated 




Representative histological images (H & E stain) of a PCL- 135 
TCP scaffold following implantation in thecalvaria of a rabbit 
after 2 weeks. Note the generalized appearance of a blood 
clot within a fibrin network (A) (1 OX magnification) and 
the intense presence of inflammatory cells detected beneath 
the non-resorbable membrane (B) (4OX magnification) 
Goldner's trichrome staining (mineralized tissue = green; 136 
osteoid = red) reveals newly formed woven bone trabeculae 
after 4 weeks along with the presence of numerous 
blood vessels distributed across the defect site (A) ( l OX 
magnification). Multi-nucleated giant cells are detected on 
the surfaces of the scaffold rods and are closely associated 
with adipose cells as early as 4 weeks after implantation (B) 
( 4OX magnification). 
Goldner's trichrome staining (mineralized tissue = green; 136 
osteoid = red) reveals an increase in volume fraction of the 
adipose cell-rich bone marrow tissue was noted rimarily after 
24 weeks following implantation (A) (1 OX magnification) 
and (B) (5X magnification). Presence of blood vessels can 





AIMS OF THE STUDY 
Chapter I 
INTRODUCTION 
Implant dentistry has become a clinically accepted and well-documented 
treatment in patients with partial or complete edentulism. 1 . 2 However, in these 
sites with missing teeth, the dentoalveolar bone is commonly inadequate or 
compromised. This is often due to the result of trauma, infection or the long­
standing physiologic atrophy from post-extraction. 3 Although the key to implant 
survival is osseointegration, one must not forget that function and aesthetics play 
a vital role in the overall implant success and patient satisfaction. It should be 
considered that an implant is the apical extension of an ideal future restoration. 
Hence, the three dimensional relationship of the implant position is critical for 
success. 3 During the replacement of missing teeth with dental implants, the 
quality and quantity of the available alveolar ridge is important in determining 
whether ridge augmentation is required prior to implant placement. 4 
Although bone possesses a large potential for regeneration, such frequently 
extended and non-contained deficient alveolar ridge, often fail to promote healing 
to its original function and structure completely. Various techniques have been 
suggested to enhance the alveolar ridge dimensions for the preparation of implant 
placement. Guided bone regeneration (GBR) is a well-proven and predictable 
technique for ridge augmentation. 5· 6 A staged approach requiring a period of 5-6 
months of healing prior to implant insertion is necessary for predictable GBR 
outcome. 7• K Various clinical studies have demonstrated that implants inserted 
subsequently after GBR procedures, show excellent long-term results and peri­
implant tissue stability. 9• 10• 1 1  
In view of the success of GBR, many studies had investigated the 
possibilities for the use of biomaterials as bone fillers and the application of 
a bioresorbable membrane as an alternative option to the conventional use of 
autogenous bone and barrier membranes. 12• 1 3• 14 Although the use of autogenous 
bone graft for alveolar bone reconstruction has been the gold standard of care, 
I\. 1 6 the use of autogenous bone grafts present 2 main disadvantages. Firstly, the 
need for a donor site results in unavoided morbidity and often insufficient volume 
of harvested bone. 17 Secondly, the unpredictability of bone resorption of the 
autogenous bone graft after ridge augmentation may lead to complications during 
implant placement or problems with stability over the grafted ridge even after 
implants have been placed. 18 In a study that used an extraoral approach for the 
harvesting of bone grafts, onlay bone grafts were obtained from the iliac crest for 
the reconstruction of severely resorbed maxilla. The authors reported dimensional 
changes to the bone grafts. They observed both horizontal and vertical resorption 
occurring over a period of 12-24 months after bone grafting have taken place. 19• 10 
22 
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A study was performed investigating bone grafts that were harvested intraorally 
from the mandible and used for augmentation purposes of localized ridge defects 
in single tooth sites. Results measured an estimate of 60% bone graft resorption in 
the horizontal direction that occurred between the time of grafting and abutment 
connection. 21 Similarly, in a study that included 15 partially edentulous patients, 
bone grafting was performed using mandibular ramus or symphysis grafts. A 
mean of 1.5mm (23.5%) of lateral graft reduction and a mean of 1.5mm (42%) 
of vertical graft reduction were reported 6 months post augmentation and prior to 
implant placement. 22 
The ultimate goal of bone tissue reconstruction is to design and fabricate 
the ideal scaffold whereby the harvesting of autogenous bone from the patients' 
donor sites can be reduced or eliminated. Recently, there have been numerous 
successful tissue engineering techniques that employed the use of various 
scaffolds in combination with bone marrow derived stem cells and/or growth 
factors. However, there has been limited research on the degradation kinetics 
regarding such scaffolds. The scaffold of choice should fulfill favorable properties 
in terms of: 23 
1 .  Biocompatibility 
2. Mechanical properties 
3. Surface characteristics 
4. Interconnectivity of the pore matrix 
5. Degradation kinetics 
POLYCAPROLACTONE 
There has been an increasing interest for the use of synthetic biomaterials 
and bone substitutes in the field of bone tissue engineering. Biodegradable polymers 
belonging to the aliphatic polyesters family, such as polylactic acid (PLA) and 
polyglycolic acid (PGA) have been used for tissue engineering research. Poly 
(i::-caprolactone) (PCL) is a semicrystalline bioresorbable polymer also belonging 
to the aliphatic polyester family, sharing similar properties with PGA and PLA 
polymers. PCL has a high molecular weight (Mn of around 50, 000). It has a low 
melting point between 59 °C and 64 °C, which enhances its processibility; and 
has a low glass transition temperature of around -60 °C, which explains its ductile 
and rubbery state at room temperature. 24 It is the latter property that contributes 
to the high permeability of PCL and allows it to form copolymer blends with 
other polymers. PCL has a higher decomposition temperature (350 °C) relative 
to other aliphatic polyesters and decomposes between 235 °C and 255 °C. In 
addition, PCL possesses favorable mechanical properties. Elastic modulus was 
23 
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reported to be between 300 and 400 M Pa (cancellous bone: 100 and 300 MPa) 
and a tensile strength that ranges from 15 and 60 MPa. 25 As a homopolymer 
belonging to the aliphatic polyester family, the repeating molecular structure of 
PCL consists of a 5 non-polar methylene group and a single relatively polar ester 
group. The presence of this hydrolytically unstable aliphatic-ester linkage in the 
structure attributed to the biodegradability of the polymer. 26 The presence of 
methylene groups on PCL also renders it non-polar; hence, PCL is hydrophobic 
and its resistance to water gives it a slow degradation profile. 21• 27 
Figure I: Chemical structure of PCL polymer 
Fused deposition modeling (FDM) has been employed in the fabrication 
of PCL scaffolds with lay-down patterns of 0/60/ 120° that result in a honeycomb­
like pattern, fully interconnected channel network and a predetermined porosity. 
28 By varying the FDM process parameters, scaffolds of customized porosity and 
mechanical properties can be achieved. PCL scaffolds have shown excellent results 
in the field of bone engineering.29 34 They have been proven to possess many of 
the desired characteristics for use as a biodegradable scaffold. Another advantage 
of PCL scaffolds is that the degradation products are non-toxic, reported mainly 
to be carbon dioxide (CO2) and water (Hp), 
15
• 36 making it relatively safe for 
medical applications. The biocompatibility of PCL has been confirmed through 
extensive in vitro and in vivo studies and has been approved by the United States 
Food and Drug Administration (FDA), namely in sutures and drug delivery 
systems. 28 
DEGRADATION OF BIODEGRADABLE POLYMERS 
Degradation behaviors of porous scaffolds play an essential role in the 
engineering of new tissue, since the rate of degradation is intrinsically linked to 
many cellular processes including cell vitality, tissue regeneration, as well as host 
response. 37 Once implanted in the body, a porous scaffold should maintain its 
mechanical properties and structural integrity until the loaded cells could adapt 
to the environment and excrete sufficient amount of extracellular matrix. During 
24 
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this time, it is expected of the scaffold to be degraded and absorbed by the body, 
enabling the space occupied by porous scaffolds to be replaced by the newly 
formed tissue. 38 If the scaffold degrades well before sufficient bone ingrowth and 
consolidation can occur, it might not be able to withstand the load bearing forces 
that are present in the oral cavity. Conversely, if the scaffold fails to degrade fast 
enough, it will act as a barrier and hinder new bone formation to take place within 
the defect. 
DEGRADATION MECHANISM OF PCL POLYMER 
The degradation kinetics and properties of PCL scaffolds have not 
been researched in detail. In general, PCL, like other members of the aliphatic 
polyesters, degrades via a 2-step degradation process. The first step is the non­
enzymatic, random hydrolytic ester cleavage, which is triggered automatically 
by carboxyl end groups of the polymer chain. Chemical structure and molecular 
weight of polymer will affect the duration of the first step of degradation. When 
the molecular weight of polymer decreases to about 5000, the second step of 
degradation will commence. The rate of chain scission and weight of polymer 
will decrease as a result of the removal of short chains of oligomers from the 
scaffold matrix. Fragmentation of polymer precedes the absorption and digestion 
of polymer particles by phagocytes or enzymes. 39 
TRICALCIUM PHOSPHATE 
Figure 2: Chemical structure of tricalcium phosphate 
Alloplastic calcium phosphate (CP) salts have been widely used in bone 
reconstructive applications in the fields of oral and orthopedic surgeries. 40 
Being bioactive in nature, these CP ceramics possess the ability of generating a 
carbonated hydroxyapatite layer that is equivalent chemically and structurally to 
the biological mineral of bone and encourage biointegration. 4 1 . 42 
25 
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Some of the more commonly used calcium phosphate bone substitutes 
include tricalcium phosphate (TCP), hydroxyapatite (HA) and biphasic CP 
ceramics. �-TCP presents as the more commonly used form is a biocompatible 
and biodegradable material used widely and successfully for bone replacement 
for many years. It has a Ca/P ratio of 1.5 and is known to be rapidly substituted 
by newly formed bone. HA is found naturally in the inorganic phase of bone 
(around 70% by weight) and is also responsible for the hardness of bone, dentine 
and enamel. It has a Ca/P ratio of 1.67. In general, HA-based bone substitutes are 
considered virtually nonresorbable or slowly resorbing. 40• 43 Biphasic CP has been 
termed by Nery and coworkers, to describe bioceramics that contain a mixture of 
HA and TCP based on x-ray diffraction analysis. 44 It has been demonstrated that 
by varying the HAffCP ratio, manipulation of the degradation rate and bioactivity 
is possible. 45 
TCP exhibit excellent regeneration activity when placed in vivo and that 
makes it a highly suitable bone regeneration material. The incorporation of a TCP 
into a polycaprolactone polymer matrix produces a hybrid or composite material. 
This bioceramic allows tailoring the desired degradation and resorption kinetics 
of the polymer matrix. 46 As mentioned earlier, due to its high molecular weight 
and hydrophobicity, PCL based scaffolds degrade at a slow rate. It is hypothesized 
that the addition of TCP can accelerate the degradation of the PCL polymer. This 
is because the TCP particles are only physically blended into the polymer and 
occupy random spaces in the polymer. Shortly after the scaffold is immersed in 
solution, the TCP particles being hydrophilic tend to fal l off and interact with the 
!>urrounding medium. The falling of TCP then create voids within the polymer, 
thus exposing their surfaces to hydrolytic attack and weakening the overal l  
structure of the PCL. 37 
POLYCAPROLACTONE TRICALCIUM PHOSPHATE SCAFFOLDS 
PCL-TCP scaffolds have been extensively studied for bone engineering 
purposes. 47·5 1  However, there has been limited report on the degradation properties 
and their use for dentoalveolar applications. As mentioned earlier, due to the high 
molecular weight and their hydrophobic nature, PCL based scaffolds have been 
shown to degrade slowly. 23• 27 This prove to be unfavorable in applications requiring 
dentoalveolar reconstruction especially when dental implants are indicated for 
insertion later within the newly regenerated bone. Our team plans to determine the 
degradation properties of PCL-TCP scaffolds. If shown unfavorable, we aim to 
further customize the degradation of the PCL-TCP scaffolds to act in concert with 
the replacement of natural host bone tissue whilst simultaneously maintaining 
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favorable mechanical properties to withstand additional physiologic stresses in 
the oral cavity. In addition, it is our team's interest to develop these scaffolds with 
desirable topographical and surface characteristics in order to allow early and 
rapid bone formation and proliferation to occur. 
AIMS OF STUDY 
In summary, the series of studies planned to evaluate the potential use of a novel 
synthetic bone substitute material (PCL-TCP) for dentoalveolar ridge augmentation. 
A systematic approach to characterize and evaluate the PCL-TCP scaffolds were 
performed in a series of in vit,v and in vivo small animal models first before 
implementing in a larger animal model. The aims of this series of studies were to: 
i. investigate the effects of different compositions of calcium phosphate 
bone substitutes on the extent of bone formation (and their comparisons 
to autogenous bone) within standardized bone defects in the mandibles of 
minipigs. The relationships of the degradation of rates of different bone 
grafting materials with respect to the amount of new bone formation 
were also discussed. The fact that TCP demonstrated an increased rate of 
degradation during the early phases of healing, which encourage greater 
new bone formation into the defects, led to our team's decision to utilize 
TCP incorporated PCL scaffolds in our subsequent in vitro and in vivo 
studies (Chapter 2); 
ii. evaluate the degradation profile of novel bioresorbable PCL-TCP scaffolds 
in vitro when immersed in culture growth medium and in vivo when 
implanted in the abdomen of rats (Chapter 3); 
111 .  investigate the effects of selective modification (via enzymatic and 
hydrolytic treatment) on the degradation and load-bearing profiles of PCL­
TCP scaffolds. Our objective was to increase the degradation rate of the 
PCL-TCP scaffolds, whilst preserving the mechanical properties, when 
used for ridge augmentation applications prior to dental implant insertion 
(Chapter 4); 
iv. evaluate the effects of sodium hydroxide (NaOH) modified PCL-TCP 
scaffolds on the structural and surface characteristics in vitro. In addition, 
analyses on early matrix and cellular deposition on the scaffold rods; 
and initial bone formation within the scaffold system will be determined 
(Chapter 5); 
v. assess the degradation profile, biomechanical properties and bone healing 
patterns of NaOH modified PCL-TCP scaffolds in a rabbit calvaria defect 
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ABSTRACT 
Objective: A novel biphasic calcium phosphate (CaP) granulate 
consisting of hydroxyapatite (HA) and �-tricalciumphosphate (TCP) was 
compared with pure HA and pure TCP and with autograft as positive control. 
Materials and methods: Four standardized bone defects were prepared in both 
mandibular angles of 16 minipigs and grafted with autogenous bone chips, HA, 
HA/ TCP (60%: 40% ), or TCP. Histologic and histomorphometric analysis of 
bone formation and graft degradation followed healing periods of 2, 4, 8, and 24 
weeks. Results: 2 weeks: more bone formation in defects filled with autograft 
than with the three CaP materials (P < 0.05). 4 weeks: bone formation differed 
significantly (P < 0.05) between all four materials (autograft > TCP > HA/ TCP 
> HA). 8 weeks: more bone formation in defects with autograft and TCP than 
with HA/ TCP (P < 0.05), and HA/ TCP had more bone formation than HA (P < 
0.05). 24 weeks: no difference in bone formation between the groups. Autograft 
and TCP resorbed quickly and almost completely over 8 weeks, whereas HA/ 
TCP and HA showed limited degradation over 24 weeks. Conclusion: All defects 
healed with mature lamellar bone and intimate contact between bone and the 
remaining graft material. The rate of bone formation corresponded to the content 
of TCP in the CaP materials. 
36 
Evaluation of a novel biphasic calcium phosphate in standardized bone defect, 
INTRODUCTION 
Alloplastic calcium phosphate (CaP) bone substitutes, such as 
hydroxyapatite (HA) and tricalcium phosphate (TCP), have been studied 
extensively due to their composition, which closely resembles the inorganic 
phase of bone tissue. 1 In general, materials consisting of HA are considered 
nonresorbable or slowly resorbable, whereas TCP-based bone substitutes are 
expected to resorb at a faster rate. 2· 3 The term 'biphasic CaP' is used to describe 
a biomaterial that consists of a mixture of HA and TCP. 4 By changing the HA/ 
TCP ratio, it has been possible to alter the substitution rate and the bioactivity of 
these materials, 5 which has led to their clinical use in oral and orthopedic surgery. 
4, 6, 7, 8 
Over the years, it has become evident that different biomaterials with 
the same chemical composition may act very differently in both in vitro and 
in vivo studies due to differences in crystallinity, crystal size, microporosity, 
macroporosity, pore size, and surface roughness. 9• ,o. 1 1 . 1 2• 13 
Crystallinity is defined as the fraction of CaP engaged in a crystal lattice 
as opposed to the fraction present in an amorphous phase, and is believed to play 
an important role in protein adsorption, cell attachment, and dissolution of the 
biomaterials. 14 The crystal size is normally dependent on the temperature at which 
the CaP is sintered. 1 1  A higher sintering temperature creates larger crystals. The 
shape, size, and distance between the apatite crystals make up the microporosity of 
the material (pores < I O  µm), which is important for the penetration and adhesion 
of macromolecules and tissue fluids. 15 The macropores (pores > 100 µm), on the 
other hand, provide a scaffold for ingrowth of new blood vessels and attachment 
of bone-forming cells, with the prerequisite that these pores are interconnected as 
seen in native bone. 9 The total volume of the micro- and macropores defines the 
porosity. In synthetic CaPs, the porosity usually does not exceed 50%, because 
a higher porosity is reported to compromise the mechanical properties of the 
ceramic. io. 16  
The aim of the present study was to investigate a new biphasic CaP 
(Straumann® Bone Ceramic) with an HA/ TCP ratio of 60/ 40, a crystallinity of 
1 00%, a macropore size of 100-500 mm, a total porosity of 90%, and a particle 
size of 0.5-1  mm in a well-documented animal model. In addition, we compared 
this HA/TCP with pure HA and with pure TCP of the same particle size and with 
identical material characteristics, except for the chemical composition, and with 
the gold standard in osseous reconstructive surgery, autografts. The histologic 
and histomorphometric evaluation focused on the comparison of pattern and 




MATERIAL AND METHODS 
The study protocol was approved by the committee for animal research, 
Canton of Berne, Switzerland (approval no. 93/ 03). The study was performed in 
16 adult Gottingen minipigs (mean weight: 55 ± 7kg (± SD)). 
Surgical procedure 
The surgeries were performed at the Surgical Research Unit, Department 
of Clinical Research and Clinic for Large Animals, University of Berne, 
Switzerland. Each animal was fasted at least 12  h before premedication with 
an intramuscular injection of ketamine 20mg/ kg body weight (Narketan® 1 0, 
I 00mg/ ml, Vetoquinol AG, Berne, Switzerland) and xylazine 2mg/ kg body 
weight (Xylapan® 20mg/ ml, V etoquinol AG). General anesthesia was induced 
by an intravascular (i.v.) infusion of atropine 0.05mg/ kg body weight ( l mg/ ml, 
Sintetica S.A., Mendrisio, Switzerland) and midazolam 0.5mg/ kg body weight 
(Dormicum®, Roche Pharma AG, Rtinach, Switzerland) through an ear vein. 
Endotracheal intubation was performed and respiration was maintained at a 
frequency of 12 breaths/ min with a volume of l Oml/ kg body weight. Isoflurane 
1 - 1.5 % (Forene®, Abbot AG, Baar, Switzerland) was added to a mixture of 
oxygen and Np (ratio I :3). 
Before surgery, the animals were given I g of prophylactic amoxicillin 
(Clamoxyl™, SmithKline Beecham AG, Thorishaus, Switzerland) intramuscularly. 
Through a subangular incision, the lateral portion of the mandibular body and 
ramus was exposed sufficiently to prepare four standardized intraosseous defects 
using a trephine with copious saline irrigation. The defects measured 7 mm in 
diameter and 4mm in depth. The trephined cortico-cancellous blocks were ground 
to a particle size of 1-2 mm using a bone mill (R. Quetin, Leimen, Germany). 
The four defects were filled with either ( I )  autogenous bone chips, (2) an HA 
granulate, (3) an HA/TCP granulate (60%:40%) (Straumann® Bone Ceramic, 
Institut Straumann AG, Basel, Switzerland), or (4) a TCP granulate. All three 
CaP materials had a particle size of 0.5- 1 mm, a macropore size of 100-500 µm, a 
total porosity of 90%, and a crystallinity of 100%. 
In each group of four animals, the augmentation material, assigned to 
the most anterior defect, was randomized. Grafting of the subsequent defects was 
rotated in a cyclic permutation in the order listed above. On the contralateral 
side, the defects were grafted identically. In this way, all grafting materials were 
represented in all defect locations on both sides of the mandible. The augmentation 
material was mixed with saline and placed into the osseous defects. Two expanded 
polytetrafluoroethylene (ePTFE) membranes (GT9, W. L. Gore & Associates Inc., 
Newark, DE, USA) were used to cover the four defects and were fixed with eight 
to nine fixation screws (Modus 1.5, Medartis AG, Basel, Switzerland). Closure of 
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the surgical sites was achieved in multiple layers using resorbable suture ( Vicryl 
3-0 and 4-0, Ethicon, Norderstedt, Germany). A fentanyl plaster (Durogesic TTS 
50 mg/ h, Janssen-Cilag AG, Baar, Switzerland) was applied for postoperative 
pain control, and 7 days of antibiotics were prescribed (Ilcocillin PS2001200, I ml/ 25 kg body weight) (Novartis AG, Basel, Switzerland). The animals were checked 
daily during the first postoperative week for signs of infection. 
Healing periods 
The 16 animals were divided into four groups of four animals, which 
were allowed to heal for 2 weeks, 4 weeks, 8 weeks, and 24 weeks, respectively. 
At the end of each designated healing period, the animals were sacrificed by 
induction of deep anesthesia, followed by withdrawal of the entire blood volume. 
The mandibles were bilaterally cut just above the mandibular foramen and anterior 
to the masseteric muscle to harvest two specimen blocks, each containing four 
defects, for histologic preparation. 
Histologic preparation 
The two harvested mandibular blocks were fixed in I 0% neutral-buffered 
formalin, combined with I %  CaCl2 for 2 weeks. A radiograph was taken to identify the exact location of the individual defects, after which each block was 
dehydrated and embedded in methylmethacrylate. Using an EXAKT® low-speed 
diamond saw with copious cooling, all defects were sectioned in the bucco­
lingual direction. A line perpendicular to the mandibular base was defined as 
the 0° axis, and the blocks were cut at either 0°, 45°, 90°, or 1 35° according to 
a randomized rotation table, yielding seven to eight consecutive undecalcified 
sections (-500 mm in thickness). The 8-week defects were only cut in the 0° axis. 
The sections were mounted on opaque Plexiglas with acrylic glue and ground to 
a final thickness of -80 µm. Finally, the sections were superficially stained with 
toluidine blue. 1 7  
Selected sections were additionally stained with tartrate-resistant acid 
phosphatase (TRAP) to identify whether multinucleated giant cells should be 
classified as osteoclasts or foreign body giant cells. 
Histomorphometric evaluation 
The three most central sections per defect were histomorphometrical ly 
analyzed by an experienced examiner who was blinded to the treatment modalities. 
Calibration was not performed systematically but on all parameters on randomly 
selected sections. The volume fractions (%) of newly formed bone, of residual 
grafting material, and of soft tissue/ marrow space occupying the defects were 
determined by point counting directly in the microscope, using a square grid 




The possibility of identical placement of the grafting materials on each 
side of the mandible allowed the calculation of a mean value per animal for all 
evaluated parameters. Thereby, the intraindividual variability could be reduced, 
and a sample size of only four animals per healing period (n = 16) was judged to 
be sufficient. Possible influences of the left vs. the right side of the mandible, the 
gender of the mini pig, and the anterior-posterior location of the bone defect were 
tested for the individual time points using Student's t-test and the Wilcoxon signed 
rank test with an a-level of 0.05. For the potential influence of other factors, the 
four time points were pooled and a mixed linear regression model was used. For 
each time point, the means and 95% confidence intervals of % newly formed 
bone, % soft tissue/marrow space, and % remaining grafting material in the 
defects were calculated using a generalized linear regression model. Friedman's 
test was used to detect differences across multiple comparisons. 
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RESULTS 
Clinical evaluation 
All minipigs remained healthy with no clinical signs of infection. 
Histology (qualitative evaluation) 
2 weeks 
Most defects grafted with autografts showed abundant bone formation 
from the defect walls, especially in defects involving the cancellous portion of the 
mandible (Fig. 1 ). However, defects grafted with the three CaP bone substitutes 
presented with sparse amounts of new bone formation. The surface of the HA 
and HA/fCP particles appeared smooth (Fig. 2), whereas the TCP particles had a 
rough surface texture and small graft fragments could be seen in the dense, cell­
rich soft tissue surrounding them (Fig. 3). 
Figure I: Defect grafted with autograft after 2 weeks. Woven bone (W) is seen almost to the 
level of the expanded polytetrajfuoroethylene membrane (Mm). Cancel/ous part of the 
mandible (C). Compact part of the mandible (Co). Undecalcified ground section stained 
with toluidine blue. 
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Figure 2: Defect grafted with HA after 2 weeks. HA particle.\ (HA)  with mwoth ,1wfaces (armws) 
embedded in a dense cell-rich co1111ective tissue (CT). U11decalcified gm1111d .1ectio11 
stai11ed with tol11idi11e blue. HA, hydroxyapatite. 
Figure 3: Defect grafted with TCP after 2 weeks. TCP particles (T) demo11strati11g w1 irregular 
s111face (thick arrow.1) .rnrro111uled by a dense cell-rich co1111ective tis.ll(e (C) co11tai11ing 
s111all frag111e111.1 of TCP (thin an'Ow.1·). U11decalcified gmw1d section sfllined with 
toluidine blue. TCP. P-tricalciw11phmphate. 
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4 weeks 
All defects filled with auto graft showed bone formation to the level of the 
ePTFE membrane, and all graft particles were embedded in newly formed bone. 
The newly formed bone had the character of a central lattice of woven bone, upon 
which parallel-fibered bone was laid down. In contrast, in the CaP-grafted defects, 
new bone most often formed in between the graft particles, occasionally bridging 
these with branches of woven bone (Fig. 4). In the majority of the defects grafted 
with TCP, woven bone substituted most of the grafting material and extended to 
the level of the ePTFE membrane. HAffCP-grafted defects showed moderate 
bone formation, whereas the least amount of new bone was seen in defects filled 
with HA. Multi-nucleated giant cells were regularly identified on the surfaces of 
HA and HAffCP, but these remained smooth, without demonstrating signs of 
resorption lacunae (Fig. 5). The soft tissue surrounding the graft particles was 
dense, cell-rich fibrous tissue without inflammatory reactions. 
Figure 4: Defect grafted with TCP after 4 weeks. The formation of woven bone (W) is mainly 
obsen1ed in between the TCP particles (T). Only a few contact zones can be identified (11). 
Undecalcified ground section stained with toluidine blue. TCP, P-tricalciumplwsphate. 
43 
Chapter 2 
Figure 5: Defect grafted with HA/TCP after 4 weeks. The HA/TCP particles (HA/TCP) are 
embedded in woven bone and a dense connectil'e tisJue (C). Multi-nucleated giant cells 
can be identified 011 the .1u1face.1· of the HA !TCP particles ( arrows). Undecalcified ground 
.1ection stained with toluidine blue. HA, hydroxyapatite; TCP. (1-tricalci11111phosphate. 
8 weeks 
All defects grafted with autograft and TCP demonstrated complete 
bone fill with woven bone and parallel-fibered bone demonstrating remodeling, 
accompanied by a more or less developed bone marrow. Only a few remnants of 
TCP granules (Fig. 6) and of the larger autograft particles could be identified in 
the defects; these were predominantly embedded in newly formed bone. The HA/ 
TCP particles were most often amalgamated with newly formed bone, the HA 
particles to a lesser extent. The presence of multinucleated giant cells was still a 
prevalent finding on those surfaces of HA and HA/TCP that were not covered with 
bone. Cells that stained TRAP-positive could be identified as osteoclast-like cells 
(Fig. 7). There were still no signs of cell-mediated resorption or dissolution of the 
smooth HA and HA/TCP surfaces, although the HA/TCP surfaces consistently 
presented with a surface zone that, in contrast to the HA surfaces, was penetrated 
by the toluidine blue staining (Fig. 8). 
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Fig11re 6: Defect grafted with TCP after8 weeks. A few remnants of the TCP particles ( anvws) can 
be identified, completely integrated in bone. The newly formed bone is predominantly 
woven bone (W) reinforced with parallel-fibered bone ( P). A mature bone marrow 
is developing (M). Undecalcified ground section stained with toluidine blue. TCP, 
P -tricalciumplwsphate. 
Fig11re 7: TRAP staining of undecalcified ground section. Defect grafted with HA/TCP after 
8 weeks. TRAPpositive multinucleated giant cells (arrows) can be obsen1ed 011 
the HA/TCP s111faces (HA/TCP). Woven bone is seen in between the particles (W). 




Figure 8: Defect grafted with HAffCP after 8 weeks. The HA!TCP particle.1· (HAffCP) are 
predomi11a11tly i11tegra1ed in woven bone (W). Parallel�fibered bone (P) i.1 Jee11 in a 
few area.1. 011 1he .1111face heading 1he de11elopi11g bo11e marrow (M), muhiple 111ulli-
1111cleated gia111 cel/1 c,111 be identified (black cmnws). A .1tai11ed m1face w11e (white 
arrows) can comi.1te11tly he observed 011 the HAffCP parlicles. U11decalcijied ground 
Jectio11 stained with tol11idi11e blue. HA, h_wlrm:w1pa1i1e; TCP. p-1ricalciu111p/10splu11e. 
24 weeks 
All defects demonstrated complete osseous healing with mature lamellar 
bone. Autograft and TCP particles could only be recognized where they had been 
integrated in woven bone in the early healing phase. The surface texture of the 
HA and HAffCP surfaces seemed more rough (Figs 9 and I 0), like the TCP 
surfaces after 2 weeks. The sparse amount of soft tissue in the HA and HAffCP 
defects had the character of the bone marrow, but still presented as more rich in 
cells and collagen fibers than the autograft- and TCP-grafted defects. In contrast 
to the HA particles, the HAffCP particles still presented with a stained surface­
near zone, as was observed after 8 weeks. 
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Figure 9: Defect grafted with HA after 24 weeks. The HA particles ( HA) are completely integrated 
in woven bone (W), parallel-fibered bone ( P), and lamellar bone ( L). The swfaces of the 
HA particleJ (HA) appear more irregular compared with earlier time points (arrows). 
Undecalcified ground section stained with toluidine blue. HA, hydroxyapatite. 
Figure JO: Defect grafted with HA/TCP after 24 weeks. The HA/TCP particles (HA/TCP) are 
completely integrated in woven bone (W), parallel-fibered bone (P), and lamellar 
bone ( L). A stained swface zone ( armws) can consistently be obsen•ed 011 the HA/TCP 





Eight defects were not included in the histomorphometric analysis: 
four 8-week defects due to the presence of an infection that could not be 
recognized clinically (two with HA and two with HAn'CP), and four additional 
defects because the quality of the histologic sections was insufficient for proper 
histomorphometric analysis (one 4-week autograft defect, one 8-week HA defect, 
and two 24-week defects combining autograft and HAn'CP). The gender of the 
minipig and the anterior-posterior and left-right positions of the osseous defects 
did not have any statistically significant impact on the healing events (P > 0.05). 
The generalized linear regression model and Friedman's test revealed that only 
the grafting material and time point had an influence on the amount of new bone 
and of remaining grafting material in the defects (P < 0.05). 
The results of the histomorphometric analysis are presented in Fig. 1 1  
and in Tables I and 2. The amount of autograft and TCP in the defects diminished 
greatly over the entire period, and especially in the early healing phase. HA and 
TCP, on the other hand, both underwent very limited degradation; this was, 
however, still significant when seen over the entire study period. 
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Figure 11: Hi!Jlomorplwmetric eva/uatio11 of the 111ea11 volume fractio11s of bo11e, grafti11g material 
a11d rnft tisrne occupying the defects. 
Treatment 2 weeks 4 weeks 8 weeks 24 weeks 
Mean (95% Cl) Mean 95%0 Mean 95%CI M ean 95%CI 
Autograft 19.3 (1 6.9-21 .6) 49.6 (45.7-53.6) 64. 1 (61-67.2) 62.8 (55.9-69.7) 
HA 6.2 (3.9-8.6) 14. 1  ( 1 0.4-17.8) 30.5 (26.3-34.7) 5 1 .3 (44.9-57.7) 
HA/TCP 6.2 (3.8-8.5) 2 1 .3 ( 17.6-25) 48.5 (44.7-52.3) 5 1 .6 (44.8-58.5) 
TCP 4.4 (2-6.7) 36 (32.4-39.7) 65.5 (62.4-68.7) 66.6 (60.2-72.9) 
Mean and 95% Cl adjusted for animal effect. 
HA, hydroxyapatite; TCP, �tricalciumphosphate; Cl, confidence interval. 
Table 1: Percellfage 11ewlyfor111ed bone occupying the defects as shown by hi.1w111017,/10111etrric anal_nis 
Treatment 2 weeks 4 weeks 8 weeks 24 weeks 
Mean (95% Cl) Mean 95%0 Mean 95%CI M ean 95%CI 
Autograft 1 9.9 (1 7.2 22.6) 9.3 (7. 1-1 1 .5) 8.5 (5.9-1 1 . 1 )  3 (1 .2-4.9) 
HA 3 1 . 1 (28.5-33.8) 26.6 (24.5-28.6) 29.8 (26.4-33.3) 22 (20.3 23.8) 
HA/TCP 26.1 (23.4-28.8) 23.8 (21 .7-25.9) 23.4 (20.2 26.5) 2 1 . 5  ( 19.6-23.3) 
TCP 26.7 (2 1 . 1-29.4) 6.9 (4.8-8.9) 2.5 (0-5. 1 )  0.8 (0-2.5) 
Mean and 95% Cl adjusted for a nimal effect. 
HA, hydroxyapatite; TCP, �tricalc1umphosphate; Cl, confidence interval. 




The aim of the present study was to compare bone formation and the 
degradation of grafting materials within standardized intraosseous defects. The 
grafting materials used were three synthetic CaP bone substitutes displaying 
identical material characteristics except for differences in the HA/TCP ratio. 
The mini pig was chosen for the present study because of its close similarity 
to humans in terms of bone healing and bone structure. 19 The created defects 
were not intended to be critical-size defects, 20 and would thus be expected to heal 
spontaneously without placement of any grafting material. 2 Creation of critical­
size defects would reduce the number of defects per side and thereby increase the 
number of experimental animals. However, because the main focus of this study 
was the comparison of the healing patterns around the different grafting materials 
and their degradation over time, the present standardized defect morphology was 
preferred, and no empty control defects were included. The ePTFE membranes 
covering the defects served the purpose of delineating the lateral boarders of the 
defects for the histomorphometric analysis, and of protecting the defects from 
ingrowing soft tissue cells and callus during the healing phase. 
Healing times from two to 24 weeks allowed the evaluation of bone 
formation from the first signs of woven bone to mature lamellar bone for all four 
grafting materials. Autograft resulted in faster bone formation initially and in an 
increased osseous maturity at 2, 4, and 8 weeks, as reported previously. 2• 3 With 
the transplantation of autogenous bone, both osteogenic cells and osteoinductive 
molecules are brought to the augmented site, 2 1 which is not the case when using 
bone substitute materials. 
Comparative in vitro studies of biphasic CaP's with different HA/TCP 
ratios have shown that the cellular attachment of osteoblasts and osteoclasts/ 
monocytes onto the CaP surface is strongly influenced by the concentration of 
TCP, in that an increased percentage of TCP leads to reduced attachment of viable 
cells on the CaP surface. 22· 23· 24· 25 This might explain why the bone formation in the 
present and previous studies mainly took place in between the CaP particles and 
to a lesser extent on the surfaces themselves. 2• 3 In contrast to the present results, 
a previous study reported an unpredictable amount of bone formation with the 
use of pure TCP in membrane-protected osseous defects. 26 The explanation for 
this diversity probably lies in the defect morphology. Membrane-protected bone 
defects in the mandibular angle ensure optimal conditions for undisturbed bone 
healing. In more demanding defect morphologies, such as lateral and vertical 
alveolar ridge deficiencies, where the bone healing only takes place from the floor 
of the defect, pure TCP degrades too fast to retain sufficient support for the bone 
formation. 26 
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Degradation of a CaP biomaterial can take place in two ways: either by 
physicochemical dissolution of the surface or by disintegration of the biomaterial 
into smaller particles which are subsequently phagocytized by macrophages or 
osteoclasts. 5• 9• 27 By both degradation pathways, the solubility product of the 
CaP is extremely important. Physico-chemical dissolution is either the result of 
equilibrium with the tissue fluids or a cell-mediated dissolution by osteoclasts. 
Such dissolution of the CaP surface results in the release of Ca2+ ions into the 
extracellular environment. Elevated extracellular Ca2+ concentrations, above 
an unknown limit, have been demonstrated to cause inhibition of osteoclastic 
resorption, detachment of osteoclasts from the surface, and ultimately cell lysis. 27 
This phenomenon may explain why only a sparse amount of osteoclast-like cells 
were observed near the surface of the highly soluble TCP particles in the present 
study. Instead, there were clear signs of disintegration of the TCP particles, 
and small fragments of TCP could be identified intra- and extracellularly in the 
surrounding soft tissues, as described previously. 9• 16  
A number of TRAP-positive multinucleated giant cells were observed on 
the surfaces of HAffCP and pure HA, especially after 4 and 8 weeks of healing. To 
make sure that in fact all the multi nucleated cells identified on the bone substitute 
surfaces were TRAP-positive, one should quantify all the TRAP-positive cells, 
grind the section a few mm, re-stain with toluidine blue, and finally quantify the 
multinucleated cells to see that these two numbers are identical. However, the 
cut and ground undecalcified sections used in the present study are not suitable 
for the quantification of TRAP-positive cells, as can be seen in Fig. 7. Therefore, 
such additional quantification was not performed. It is thus possible that a fraction 
of these multi-nucleated giant cells in fact were foreign body giant cells. The 
presence of osteoclast-like multi-nucleated giant cells like these has previously 
been reported on the surfaces of synthetic and xenogenic bone substitutes, 
without being associated with the characteristic resorption lacunae observed in 
normal remodeling of native bone and autografts. 3· 9· 28 It has correspondingly 
been shown in tissue cultures that although osteoclasts are able to adhere to CaP 
surfaces, this does not necessarily mean that these cells are able to resorb them. 
1 3• 29 It has been suggested that the osteoclast-like cells have the same function 
as macrophages - i.e., to clean the graft surface to prepare it for the deposition 
of newly formed bone. This idea is supported by the fact that the multinucleated 
cells were often observed just adjacent to bone-forming osteoblastic rims. 
An ongoing experimental study will compare the presence and role of 
these multinucleated giant cells in relation to HAffCP and anorganic bovine 
bone. It was expected that HAffCP would degrade at a faster rate than pure HA, 
in accordance with previous in vitro and in vivo studies showing that the amount 
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of TCP in a CaP biomaterial was directly related to the degree of degradation of 
the biomaterial. 5• 2 1  This was not the case, however, because the materials showed 
equal but limited amounts of degradation over the 24 weeks of healing. It has 
been documented previously that biphasic CaPs with identical ratios of HA and 
TCP could elicit increased dissolution if the porosity was reduced, the crystal 
size increased, or the crystallinity increased. ' The HAffCP tested in the present 
study was characterized by a crystallinity of I 00%, which may be the reason 
for its low substitution rate, even though a total porosity of 90% should pull in 
the opposite direction. 5 Although no differences could be demonstrated with 
regard to the degradation rate between pure HA and HAffCP, bone formation 
was faster with HAffCP, which suggests that the TCP content in HA/fCP had 
some effect on the healing events. The dye penetration of the outer layer that 
was consistently observed on the HA/TCP particles after 8 and 24 weeks, but 
not on the HA particles, may have been the result of a superficial dissolution 
of the TCP part of the biphasic material. It has been shown previously that 
superficial dissolution of biphasic CaP apatite crystals favors reprecipitation of a 
biologic apatite layer on the surface of the biomaterial, which in turn facilitates 
osteoconduction. 2'1 In addition, increased concentrations of free calcium ions in 
the defect may have the function of a calcium reservoir for bone formation to 
take place at a distance from the CaP surface, as long as the environment does not 
become supersaturated and thereby initiate cell lysis. 27 In conclusion, all defects 
ultimately healed with equal amounts of mature lamellar bone, but the rate of 
bone formation was decelerated in the early healing phases in defects grafted 
with the CaP bone substitute materials as compared with particulated autografts. 
The rate of new bone formation was directly dependent on the TCP content of the 
three CaP biomaterials. HA and HAffCP exhibited similar resorption patterns 
at a very limited rate, whereas autograft and TCP showed fast degradation and 
substitution by newly formed one. Biphasic CaP with a slow substitution rate 
may be a suitable bone substitute material for volume expansion of particulated 
autogenous bone grafts and in areas where a resorption barrier is needed, such 
as around autogenous bone block transplants. Additional studies currently being 
performed are exploring whether other ratios of HA/TCP may contribute to the 
field of bone regeneration, and how the present combination of HA/TCP can act 
as a carrier for bone-stimulating proteins. 
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ABSTRACT 
Degradation studies of scaffolds are important in bone tissue engineering. 
Previously, novel poly(E-caprolactone)-20 % tricalcium phosphate (PCL-TCP) 
based scaffolds were developed and proven useful for bone regeneration. In this 
study in vitro degradation analyses were carried out with the PCL-TCP scaffolds 
immersed in standard culture medium for 24 weeks. In vivo degradation was 
performed with the scaffolds implanted in the abdomen of rats for the same 
period of time. Results demonstrated greater degradation of PCL-TCP scaffolds 
in vivo than in vitro. At 24 weeks, the increase of average porosity of the scaffolds 
in vivo was 29.2 % compared to 2.65 % in vitro. Gel permeation chromatography 
(GPC) analysis revealed a decrease of 29 % and 20 % respectively in the Mn and 
M values after 24 weeks in vitro. However, a significant decrease in M and M w n w 
values (79.6 % and 88.7 % respectively) were recorded in vivo. The mechanical 
properties however, were relatively similar and closely match those of cancellous 
bone even at 24 weeks. The results showed that the scaffold can be used for 
dentoalveolar reconstruction and PCL-TCP scaffolds have shown to possess the 
potential to degrade within the desired time period of 5-6 months and favorable 
mechanical properties. 
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INTRODUCTION 
In implant dentistry, trauma and disease result in severe defects and 
deformities. These conditions prevent or delay the subsequent insertion of dental 
implants as the affected bone is of insufficient volume for successful reconstruction 
to occur. The use of autogenous bone has been the most predictable approach for 
regeneration of new bone. 1 -3 However, the requirement for additional surgery 
from a donor site coupled with often insufficient donor volume has encouraged 
the need for an alternative treatment. 4 One objective of bone tissue engineering 
is to restore form and function to lost and defective tissues. Tissue-engineered 
scaffolds serve as 3D architectures for structural support, void maintenance and 
cellular conduction within the system. 5 The degradation profile of such scaffolds 
must correspond to the regenerative rate of the affected tissue type in order for 
concomitant ingrowth and replacement to occur. Specifically for dentoalveolar 
reconstruction, a scaffold that degrades between 5-6 months is considered ideal 
for bone regeneration and remodeling. 6• 7 Bone is a functionally demanding organ 
and so the scaffold also has to be of sufficient strength initially to withstand the 
stresses of mastication until the newly regenerated bone takes over. 
Polycaprolactone-20 % tricalcium phosphate (PCL-TCP) scaffolds 
are produced by advanced fused deposition modeling techniques. 8 These 
bioresorbable scaffolds possess a completely interconnected architecture with a 
regular porous morphology that is favorable for cellular conduction 9 as well as 
protein loading and release. 10• 1 1  In addition, PCL-TCP scaffolds recently revealed 
a bioactive nature by nucleating the formation of hydroxyapatite on its surface 
when soaked in simulated body fluids 1 2 •  It should be noted that the predicate 
device, pure PCL scaffolds, are FDA approved for craniofacial indications but 
are slow degrading scaffolds not optimal for implant dentistry. The degradation 
of PCL-TCP scaffolds has not been fully understood. The addition of TCP was 
hypothesized to accelerate the degradation of the PCL scaffold. 
This study aimed to investigate ( I )  the in vitro degradation profile 
for PCL-TCP scaffolds when immersed in standard culture medium under 
physiological conditions for 24 weeks and (2) the in vivo degradation profile for 
PCL-TCP scaffolds when implanted in the abdomen of rats for 24 weeks. The 
profile included changes in molecular weight, porosity, mechanical properties 
and surface morphologies. 
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MATERIALS AND METHODS 
Scaffold d esign and fabrication 
The PCL-TCP (80: 20%) composite scaffolds were purchased from 
Osteopore International Pte Ltd, Singapore. The composites manifested a lay 
- down pattern of 0/60/ 120° and porosity of about 70 %. The scaffolds were 
produced as blocks of 50 x 50 x 3 mm. Cylinders measuring 5 mm in diameter 
and 3 mm in height were cored using a trephine, and used for both the in vitro and 
in vivo studies. 
The scaffolds were first pretreated in 5M NaOH for I hour, followed by 
rinsing three times in Phosphate Buffered Saline (PBS, 137 mM NaCl, 2.7 mM 
KCI, I O  mM Na2HPO4, 1.8 mM KH2PO4, pH 7.4). They were then sterilized in 70 
% ethanol for 24 hours and rinsed twice in PBS. The scaffolds were subsequently 
dried in humidified atmosphere at 37 °C and 5 % CO
2 
for I h before used for the 
experiments. 
In vitro degradation study 
Pre-wetting of scaffolds 
The scaffolds were placed into individual wells of 24-well tissue culture 
plates containing Dulbecco's Modified Eagle Media (DMEM) culture medium. 
The plates were stored in an incubator at 37 °C for 24 weeks and at respective time 
points (weeks 2, 4, 8, and 24), 9 scaffolds samples were removed for evaluation. 
The culture medium was replaced every three days. The pH of the supernatants 
was measured prior to every solution change using a calibrated pH meter. pH 
measurements were also taken from buffer solutions that did not have any 
submerged specimens scaffolds (controls). The test methods at each time point 
included gravimetric analysis, micro-computed tomography imaging (micro-CT), 
scanning electron microscopy (SEM), gel permeation chromatography (GPC) 
analysis and mechanical testing. 
Gravimetric Analysis 
Prior to immersion in growth medium, the initial weight (W0) of all 
the specimens was measured. At the respective time periods, specimens were 
removed and blotted dry with a piece of clean tissue paper to get rid of excess 
buffer solution adhering to the surface, weighed and later, dried to constant weight 




Fluid uptake (%) = wet O x 100% 
WO 





respectively, are weights of the wet and starting dry weight 
scaffolds as measured at time, t. Values obtained for triplicate samples were 
averaged. All weights were measured to an accuracy of + 0.0 I mg. 
Following that, the specimens were dried for 48 hours in an incubator 
that maintained a temperature of 37 °C and controlled humidity of 30 %. The dry 
weights of the 3 specimens were then recorded down (Wdr)· The percent weight loss of the specimens was calculated as follows: 
WO - Wdry Weight loss (%) = ---- x I 00% 
WO 
Micro-CT analysis 
The changes in porosities and morphologies of the PCL-TCP scaffolds 
after immersion in culture medium were detected using the SkyScan 1076 in vivo 
x-ray microtomograph system (SkyScan 2002, Belgium). The samples (n = 3) 
were placed on a 35 mm diameter object bed. Before doing a complete scan, a 
single 2 dimensional X -ray scout scan was performed to determine the position 
of the scaffolds in the scanning chamber. After which, a complete scan (energy = 
104 KV; intensity = 98 µA; pixel size = 35 µm) was performed. The scanned slices 
were reconstructed using the Cone Beam program. The 3D-Creator program was 
then used to convert the reconstructed dataset into 3D images. The porosities, 
trabecular thickness, separation and number of the samples were calculated using 
the associated CT analyzer software. "Trabecular" in this manuscript refers to the 
rods of the scaffolds. 
SEM analysis 
Surface morphological changes of the PCL-TCP scaffolds were 
characterized using scanning electron microscopy. The samples were fixed in 2.5 
% gluteraldehyde (Sigma, Germany) at 4 °C overnight. They were then dehydrated 
in a graded ethanol series of 25 %, 50 %, 75 %, 95 % and 100 %, air-dried and 
gold-sputtered with JFC-1200 fine-coater for 30 s at 10 mA under high vacuum. 
The specimens were examined with a JEOL JSM 5600LV SEM operating at 15 
kV under high vacuum mode. 
Gel permeation chromatography (GPC) analysis 
The number-average (Mn) and weight-average (M) molecular weights 
of the scaffolds at the respective time points were determined by gel permeation 
chromatography equipped with an Isocratic HPLC pump (Waters, model 1500 
series), an absorbance detector (Waters, model 2487) and a refractive index 
detector (Waters, model 2414). The samples were first dissolved in HPLC grade 
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Tetrahydrofuran (THF) to produce a 1 % w/v solution. These solutions were 
then filtered using a 0.45µm syringe filter before loading into the GPC columns. 
GPC measurements were carried out at 30°C and at a flow rate of 1 ml/min using 
THF as the mobile phase solvent through a Styragel column refractor (Waters). 
Polystyrene standards (Polyscience Co.) ranging from molecular weights of 
2750000 to 1200 were used for calibration. 
Mechanical Testing 
The compressive mechanical properties of PCL-TCP scaffolds were tested 
using the Instron 3345 mechanical testing machine and a I KN load cell. Five wet 
sample scaffolds at each time point were used. The test was conducted at 23 °C 
and the scaffolds were compressed at a crosshead speed of l mm/min for up to 80 
% of the scaffolds total thickness. A stress - strain curve was then plotted using 
the experimental data (load versus deformation) and the compressive modulus 
and strength was recorded for each specimen, with the stiffness being measured 
as the slope of the linear portion of the curve. 
Ill vivo degradation study 
Surgical Procedures 
Three, 7-week old Fishers' male rats were operated under general 
anaesthesia, which consisted of an intraperitoneal injection of ketamine and 
xylazine mixture (75 mg/kg + 10 mg/kg). Their abdominal cavities were shaved 
and scrubbed with iodine, followed by disinfection with 70 % ethyl alcohol, and 
an incision was later made. For each rat, four samples of cylindrical PCL-TCP 
scaffolds were placed into the empty spaces of the abdominal cavity, avoiding any 
major organs, and the skin was closed with vicryl sutures. Buprenorphine (100-
500 µg/kg) and cephalexin ( 15-20 mg/kg) were given subcutaneously for 3 and 5 
days respectively. Housing and feeding of the animals were performed according 
to standard animal care protocols. The study was approved by the Animal Welfare 
Committee, National University of Singapore, licensed according to the National 
Institutes of Health Guide for the Care and Use of Laboratory Animals. The rats 
were euthanized by an overdose of carbon dioxide inhalation and the scaffolds 
were removed after 24 weeks. The extracted scaffolds were stored in centrifuge 
tubes of PBS solution and Neutral Buffered Formalin (NBF) (for histological 
specimens only) and kept at -20 °C and room temperature respectively until 
testing. Most of the evaluation methods were similar to the in vitro studies and 
are described in section 2.2. 
Histological Analysis 
The two specimens removed after 24 weeks and stored in NBF were 
dehydrated in ascending series of alcohol rinses and embedded using a process that 
produced ground sections with the glycol metacrylate resin. Once polymerized, 
62 
The degradation profile of novel, bioresorbable PCL-TCP scaffolds: An in vi11v and in vivo study 
the block was trimmed to remove excess plastic with an industrial vertical band 
saw and cut along its long axis with a diamond band saw (EXAKT standard 
saw). Ground polished sections of I O  µm thickness were made using the EXAKT 
micro grinder system from EXAKT Technologies, Inc., Oklahoma City, OK. Two 
slides were created for each scaffold. The slides were stained with Hematoxylin 
& Eosin. 
Statistical Analysis 
All quantitative data were expressed as mean ± standard deviation. 
Statistical analysis was performed by Student's t test using Instat Software 
(GraphPad Software, Inc., San Diego, CA, USA) for comparisons between 
different time points. A value of p < 0.05 was considered to be statistically 
significant. 
RESULTS 
In vitro degradation study 
pH measurements 
The pH of the scaffold-soaked culture medium remained relatively 
constant at pH 8 until week 14, after which, the pH became increasingly alkaline 
and reached a final value of 9 .4 at 24 weeks (Fig I ). The pH of the control, that is, 
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Figure 1: The pH of culture medium after immersion with PCL-TCP scaffolds as a function of 




Gross examination revealed that there were significant changes to the 
PCL-TCP scaffolds after 24 weeks (Fig 2 (A)). There was a reduction in the 
dimensions of rods and the overall cylindrical shape was Jost as compared to 
week 0 samples. Figure 2 (B) shows the percentage fluid uptake of scaffolds 
in culture medium over various time points. It was observed that fluid uptake 
increased between weeks 0 to 8, after which it declined until week 24 (p < 0.05). 
Measurements for percentage weight loss showed a significant increase from 
weeks 8 to 24 (p < 0.05) (Fig 2(C)). 
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Figure 2(B): The percellf ll'ater uptake by PCL-TCP scaffold.1 i111mer.1ed in culture medium a.1 a 
jimction of time (11 = 3). 
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Figure 2(C): The percent weight loss by PCL-TCP scaffolds immersed in culture medium as a 
f1111ctio11 of time (11 = 3). 
Micro-CT analysis 
There was a gradual increase in overall porosity of the scaffolds after 8 
weeks of immersion in culture medium. However, the increase was not statistically 
significant (p > 0.05). Figure 3 illustrates the 3D images of the scaffolds before and 
after soaking for 24 weeks. There were obvious changes to the 3D morphology 
of the scaffolds. The honeycomb-like architecture with the interconnected pores 
present in predicate scaffolds was lost at 24 weeks. The rods appeared to have 




Representative micro-ct images of PCL-TCP scaffolds immersed in culture medium 




The PCL-TCP scaffolds immersed in culture medium demonstrated 
significant changes to its surface morphology over time as depicted in Fig 4. 
At week 0, the scaffold had a consistent interconnected architecture and under 
higher magnification, the TCP was evident as particles within the rods' surfaces, 
giving it a rough texture. After soaking in growth medium for 8 weeks, cracks 
were observed and flakes developed that appeared to peel off from the rods. After 
24 weeks, most of the first layer of rods had dissolved away. The architecture 







Representative scanning electron micrograph.1 of PCL-TCP scaffolds immersed in 
culture medium for (A-B) 0, (C-D) 8 and (E-F) 24 weeks. 
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GPC analysis 
The graphs of Mn and Mw are shown in Figure 5 (A) and (B) respectively. 
The PCL-TCP scaffolds exhibited a statistically significant decrease in its Mn and 
Mw of 29 % and 20 % respectively, after immersion in culture medium for 24 
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Figure S(A): The number average molecular weight (Mn) of the PCL-TCP Jcaffolds after 
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Figure S(B): The weight average molecular weight (Mw) of the PCL-TCP scaffolds after 




Figure 6 (A) demonstrates a significant increase of 98 % in the compressive 
modulus of the PCL-TCP scaffolds immersed in culture medium for 24 weeks (p 
< 0.05). The final modulus measured was 45.7 ± 5.43 MPa. The compressive 
strength data however, revealed a significant decrease of 50.2 % after 24 weeks 
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Figure 6(A): The compressive modulus of the PCL-TCP scaffolds after imme,:�ion in culture 
medium as afimction of time (n = 3) . 
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Figure 6(B): The comprcs.1ive lfrength of the PCL-TCP .1caffolds after immersion in culture 
medium as afimction of time (n = 3). 
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Ill vivo degradation study 
Gravimetric analysis 
The percentage of the fluid uptake by the scaffolds after implantation for 
24 weeks was increased by 31 .9 % (Week 0: 65. 1  mg ± 9.09,  Week 24: 85.9 mg ± 
I 2.0) (p < 0. 1 ). The weight measurements revealed a decrease of 7.94 % (Week 0: 
65. 1  mg ± 9.09 , Week 24: 59.9 mg ± 14.9) after 24 weeks (p < 0. 1). 
Micro-CT analysis 
Figures 7 (A) and (B) illustrate the 3D structure of the scaffolds before and 
after implantation in vivo for 24 weeks respectively. The interconnected architecture 
of the scaffolds was lost at 24 weeks. The surfaces throughout the entire volume 
of the cylindrical scaffolds were rough and highly distorted, and the pores could 
not be discerned. Figure 7 (C) shows the porosity, trabecular thickness, trabecular 
separation and trabecular number of the scaffolds (as measured by micro-CT 
analysis) before and after implantation in vivo for 24 weeks. The average porosity 
of scaffolds at week 24 was 0.86 ± 0. 1 ,  which was an increase of 29.7 % from 
week 0. This was a statistical trend (p < 0. I ). There were no statistically significant 
changes to the other parameters, except for the trabecular number (proportional to 
the number of rods) that declined by 29.2 % (Week 0: 0.96 ± 0. I ,  Week 24: 0.68 ± 
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Represelltative micro-ct images of PCL-TCP scaffolds implantation in rats for (A) 0 and 
( B) 24 weeks. ( C) The micro-ct measurements of po,vsity, trabernlar thid.ness, trabecular 
separation and trabernlar number of the PCL-TCP scaffolds after implallfation in rats 
for 24 weeks. Data are shown m mean ± SD. (*) Statistirnlly fig11ifica11t (p < 0.05) mean 
trabecular number between week 0 and week 24. 
SEM analysis 
Figures 8 (A) and (B) display SEM micrographs of the scaffolds under 
low and high magnifications respectively, after implantation for 24 weeks in vivo. 
The honeycomb-like pattern of triangular pores present in scaffolds at week 0 
was lost at week 24 and the rods had melted and fused together. The surface of the 
scaffolds has become rough and highly distorted. This correlates with the findings 
from micro-CT analysis. 
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Repre5entative scanning electron micrographs of PCL-TCP scaffolds implantation in 
rats for 24 wee/..5. (A) and (B) represent low and high magnifications re5pectivel), 
GPC analysis 
The number-average and weight-average molecular weight of the 
scaffolds exhibited a significant decrease after implantation for 24 weeks in vivo 
by 79.6 % (Week 0: 59 676 ± I 237, Week 24: 12 204 ± 252) and 88.7 % (Week 
0: I I 3 394 ± 2 089 ,  Week 24: I 2 869 ± 237) respectively (p < 0.05). The results 
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Week 24 
Figure 9(A): The number average molecular weight (Mn) and weight average molecular weight 
(Mw) of the PCL-TCP scaffolds after implantation in rats a5· a function of time 
(11 = 3). Data are shown as mean ± SD. (*) Statistically 5 ignificant (p < 0.05) mean 
trabecular nwnber between week 0 and week 24. 
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Mechanical testing 
The compressive properties of the scaffolds as a function of degradation 
time are depicted in Figure 9 (B). Both the compression strength and modulus 
have decreased significantly after the 24 weeks implantation by 37.2 % (Week 0: 
6.38 ± 0.82, Week 24: 4.0 1 ± 0.47) and 67.0 % (Week 0: 23. 1 ± 6. 16, Week 24: 
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• Compressive Strength 
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Figure 9(8): The c0111pre.1·.1·i1•e Hre11gth and 111od11/11.1 of the PCL-TCP scaffolds after i111pla11tatio11 
in rat.I a.1 a Jw1ctio11 of time (11 = 3 ). Data are 1/1011111 a.1 mean ± SD. ( *) Statistically 
sig11ijicw1t (p < 0.05) mean trabecular 1111mber between week 0 and week 24. 
Histological analysis 
Figure I O  (A) shows a representative histological section of the scaffold 
after implantation in vivo for 24 weeks. Interestingly, the pores of the scaffolds 
were completely infiltrated with soft tissue, specifically adipose tissue, which was 
identified by their distinct anatomical features. The cells were observed in direct 
apposition to the rods of the scaffolds. The adipose cells were large, ranging 
in size from 100-200 microns and separated into lobules by septa composed of 
dense connective tissue as shown in Figure 10  (B). Numerous vascular vessels 
were interspersed as well. Presence of overt inflammatory cells or fibrous 
encapsulation was not detected. Macrophages or multinucleated giant cells were 
also absent (Figure I O  (C)) 
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Figure JO(A): A represelltative histological image of the PCL-TCP scaffold after implantation in 
rats for 24 weeks, stained with hemato.\)'lin-eosin. Note the depo.1ition of adipose 
tissue with blood vesJe/s i11tersper.1ed within the pore, right next to the ,vd of the 
scaffold. ( /OX magnification) 
Figure JO(B): A histological section of a typically healthy and regular-shaped adipose tissue fowul 
within the pores of the PCL-TCP scaffold at 24 weeks, stained with hemato.\)'li11-
eosi11. (40X mag11ification) 
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Figure JO(C): A histological section of part of a blood vessel found adjacent to the PCL-TCP 
scaffold at 24 weeks, .1 tained with hematoxylin-eosin. Note the presence of red blood 
cells found within the vessel. (40X magnification) 
DISCUSSION 
The breakdown of synthetic scaffolds first occurs by autocatalysis with 
non-enzymatic random hydrolytic chain scission of ester linkages. A second 
stage of degradation occurs as the mechanical strength and weights are lost, 
thereby increasing the surface area for greater bioerosion. 1 1 The final breakdown 
products of PCL were reported to be CO2 and Hp. 
1 4• 15 The in vivo degradation 
of PCL was monitored for 3 years in rats previously. The results showed that PCL 
capsules with initial molecular weight of 66000 remained intact in shape during 
the 2-year implantation. It broke into low molecular weight (8000) pieces only at 
the end of 30 months. 16 
The addition of TCP was hypothesized to accelerate the degradation 
of the PCL scaffold. The first objective of the current study was to monitor the 
in vitro degradation profile of PCL-TCP scaffolds when immersed in standard 
culture medium that was used as it contains vitamins, amino acid and glucose 
and is closer to the human blood composition. Hence, the results obtained would 
be more clinically relevant. This study revealed that the pH became increasingly 
alkaline and attained a pH of 9.4 after 24 weeks (Figure 1 ). TCP particles that 
were only physically blended with PCL are hydrophilic and alkaline in nature. 
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Prior work showed that upon immersion in culture medium, it dislodged and 
precipitated on the surface of the scaffolds 1 2• This could be the reason why 
there was a noted increase in pH of culture medium after 24 weeks. The alkaline 
environment formed is deemed harmless to the human body. A previous study 
compared PCL and PLGA (polylactic-glycolic acid) scaffolds implanted 
subcutaneously into the backs of mice. Undesirable adverse reactions including 
inflammation and cell death were reported in the more acidic PLGA environment 
as compared to the PCL scaffolds. The PLGA scaffolds demonstrated less cell 
mobilization and angiogenesis, due to the acidic environment resulted from the 
degradation by-products. 17 It has been shown that if the by products of implanted 
scaffolds cause an acidic environment, an inflammatory response in the human 
body would be activated resulting an undesirable reaction in the body. 1 3  
The present study demonstrated that when immersed in culture medium, 
the PCL-TCP scaffolds displayed distinct surface changes. Distortions and 
cracks on the surfaces of the scaffolds were observed from the scanning electron 
micrographs as early as 8 weeks (Figure 4C, D). At 24 weeks, significant 
degradation and reduction in the dimensions of the scaffolds were reported 
(Figure 4E, F). This corresponded with the gravimetric analysis, which showed 
an estimated 60 % weight loss of scaffolds when compared from baseline (Figure 
2C). When indicated for dentoalveolar reconstruction, scaffolds should ideally 
degrade between 5-6 months for optimal bone regeneration and remodeling 
to take place within the defect prior to implant placement. 6· 7 Since 40 % by 
weight of the PCL-TCP scaffolds remained after 6 months in vitro, there may be 
a need to accelerate the rate of degradation of the scaffolds. Micro-CT analysis 
revealed that there were no significance changes in the porosities of the PCL-TCP 
scaffolds after immersion in culture medium for 24 weeks. It has been shown 
that the percentage change in weight loss is related to the porosity of the scaffold 
during degradation. 18 Here, the non-statistical percentage change of porosity 
but significant weight loss suggests that selective degradation was taking place 
only on the surfaces of the PCL-TCP scaffolds and with bulk volume reduction, 
without affecting much of the pore size or geometry. This finding is in accordance 
to the percentage change in fluid uptake being statistically insignificant (Figure 
2B), since the percentage of fluid uptake is dependent on the porosity of the 
scaffold. The compressive strength of PCL-TCP scaffolds immersed in culture 
medium was significantly reduced (50 %) after 24 weeks (Figure 6B). The results 
correlated to the gravimetric analysis and gel permeation chromatography data, 
which indicated significant degradation and weight loss only at 24 weeks. Both a 
significant weight and molecular weight loss suggests that the scaffolds were in 
its second stage of degradation (Figure 5A, B). 
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The second objective of the study was to investigate the in vivo degradation 
profile of PCL-TCP scaffolds implanted in the abdomen of rats for 24 weeks. The 
abdomens of rats were selected to test the scaffolds in an aggressive environment. 
This study showed that the in vitro and in vivo degradation rates of PCL-TCP 
scaffolds were different. During the period of implantation of 24 weeks, the 
PCL-TCP scaffolds exhibited major degradation and changes in the surface 
morphology. Scanning electron micrographs demonstrated obvious distortion 
and increased surface roughness of the scaffolds. Also, the distinct honeycomb-
1 ike architecture of the pores present in original PCL-TCP scaffolds was lost 
(Figure 8A, B). Micro-CT scans revealed similar changes to the overall 3D 
framework and considerable reduction in size (Figure 7 A, B). In addition, a 29.7 
% increase in the average porosity of the scaffolds was noted. Interestingly, the 
PCL-TCP scaffolds tested in this study maintained their pore interconnectivity 
as they became more porous. This is advantageous as it would encourage the 
development of a vascular network to allow for the infiltration of nutrients, cells 
and growth factors within the system. 5 
In our study, in vitro and in vivo degradation of PCL-TCP scaffolds 
behaved differently over the course of 24 weeks. The extent of degradation of 
PCL-TCP scaffolds in vivo was greater than in vitro immersed in culture growth 
medium. When implanted in the abdomen of rats, the scaffolds generally degrade 
more rapidly. At 24 weeks, the increase of average porosity of the scaffolds in 
vivo was 29.2 % compared to 2.65 % in vitro. Using SEM, although both groups 
demonstrated significant changes to the surface morphology of the PCL-TCP 
scaffolds, the scaffolds in vitro still retained much of the architecture whereas in 
vivo much of the architecture have been highly distorted. GPC analysis revealed 
a decrease of 29 % and 20 % respectively in the M and M values when scaffolds 
n w 
were immersed in growth medium after 24 weeks (Figure SA, B). However, when 
compared to scaffolds implanted in the abdomen of rats, a significant decrease in 
M11 and Mw values (79.6 % and 88.7 % respectively) were recorded (Figure 9A). 
The mechanical properties however, were relatively similar and closely match 
those of the cancellous bone even at 24 weeks (Figure 9B). 
At 24 weeks of implantation, the scaffolds showed an increase of 3 1.9 % 
in fluid uptake, which corresponded to the increase in porosity as quantified by the 
Micro-CT analyzer. These results suggest the possibility of both rod surface and 
pore degradation occurring simultaneously in an in vivo environment during the 
24 weeks implantation period. Gel permeation chromatography measurements 
demonstrated a 79.6 % and 88.7 % decrease in M and M of the PCL-TCP 
n w 
scaffolds respectively. At the end of 24 weeks, the Mw recorded 12, 869 Daltons. 
This implies that the majority of the first stage of degradation (the random scission 
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of the carbon chains) had already occurred and not long before the second stage 
of degradation begins to takes place. 1 2  
A main limitation of synthetic biodegradable scaffolds is the mechanical 
properties. The PCL-TCP scaffolds used in our study recorded an average 
compressive strength of 6.38 MPa at baseline, which closely matches to that 
of human cancellous bone. 19 This suggests that the PCL-TCP scaffolds have 
reasonable mechanical strength to withstand load-bearing masticatory forces in 
the oral environment while simultaneously allowing for cellular proliferation, 
differentiation and maturation to occur. Both the compressive strength and 
modulus (stiffness) decreased significantly after implantation for 24 weeks by 
37 .2 % and 67 .0 % respectively. This is in line with our strategy for dentoalveolar 
reconstruction, whereby the PCL-TCP scaffolds should gradually lose its physical 
properties until 5-6 months when the regenerated bone can support itself. 
Histological sections of the scaffold after implantation in vivo for 24 
weeks were stained with hematoxylin-eosin and analyzed (Figure A, B, C). In 
all scaffolds, the pores were completely infiltrated with largely adipose tissue 
along with numerous vascular vessels that were interspersed. These cells were 
observed in direct apposition to the rods of the scaffolds and are generally healthy 
in appearance. The presence of overt inflammatory cells or fibrous encapsulation 
was not detected. One of the main characteristics of the pathological response 
(foreign body reaction) to a biomaterial is the presence of multinucleated giant 
cells. Macrophages or multinucleated giant cells were not detected suggesting the 




As expected, PCL-TCP scaffolds degraded at a more rapid rate when 
implanted in an in vivo environment. At 24 weeks, the PCL-TCP scaffolds 
demonstrated a significant extent of degradation; while maintaining mechanical 
properties that closely matched those of the cancellous bone. This would prove 
highly advantageous in terms of structural support as the newly mature bone is 
formed while the scaffold is being degraded. Additional studies are being carried 
out to determine an ideal initial porosity of the scaffolds that will degrade within 
a 5-6 months period to allow favorable new bone formation to occur throughout. 
The results from our study demonstrate that the PCL-TCP scaffolds offer an 
exciting approach to dentoalveolar regeneration. 
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ABSTRACT 
The degradation of polycaprolactone-20% tricalcium phosphate (PCL­
TCP) scaffolds was customized for dentoalveolar augmentation applications, 
where 5-6 months period is optimal. The scaffolds were treated with either 3M 
sodium hydroxide (NaOH) or 0. 1 % lipase solution for a total of 108 hours. A 
greater degree of degradation and reduction in the physical properties of the 
scaffolds was observed in the lipase-treated as compared to NaOH-treated 
scaffolds. After l 08 hours, increases in weight loss and average porosity of the 
scaffolds in the lipase-treated group measured 90.6% and 22.9% respectively 
as compared to 52.8% and 11.8% in the NaOH-treated group. The mechanical 
testing results revealed a similar trend, with a complete loss of compressive 
strength and modulus measured as early as 60 hours in the lipase-treated group. 
The honeycomb-like architecture was well preserved throughout the experiment 
only for the NaOH-treated scaffolds in addition to a favorable surface roughness 
ideal for bone regeneration applications. In conclusion, pretreatment with 
NaOH demonstrates a simple approach for tailoring the physical properties and 
degradation rate of PCL-TCP scaffolds for the potential use as biomaterials 
targeted for dentoalveolar bone regeneration procedures. 
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INTRODUCTION 
The ultimate goal of bone tissue engineering is to develop a strategy 
whereby the need for an extensive bone harvesting procedure can be avoided. 
In the case of dentoalveolar reconstruction, besides displaying biocompatibility, 
the bone grafts need to degrade predictably over an optimal period of 5-6 months 
whilst allowing new bone formation to occur and replace accordingly. 1 . 2· 3 They 
also need to be of sufficient mechanical strength to withstand the moderate load­
bearing forces in the oral cavity. 4 
Our group has been actively testing a novel bioresorbable scaffold 
consisting of 80% PCL and 20% TCP. The scaffolds demonstrated a bioactive 
nature by nucleating the formation of hydroxyapatite on its surface upon 
immersion in simulated body fluids. 5 In addition, PCL-TCP scaffolds proved 
to be effective in the delivery of growth factors, namely bone morphogenetic 
proteins (BMPs) and platelet-rich plasma 6· 7• 8 and in stimulating osteogenesis in 
critical-sized rat femoral 9 and dog mandibular defects. 10 
The degradation profile of PCL-TCP scaffolds in vitro and in vivo was 
recently documented. 1 1  Results showed that a decrease of 20% by molecular 
weight-average of the scaffolds resulted after 6 months when immersed in growth 
medium and an 88.7% reduction of molecular weight-average was reported after 
implantation in the aggressive environment of the rats' abdomen after 6 months. 
The above data suggests a need to accelerate the rate of degradation of the PCL­
TCP scaffolds to a period of 5-6 months in line with our strategy for dentoalveolar 
reconstruction applications. 
There has been an increasing trend for researchers to investigate cellular 
responses on surface topography and characteristics. Surface properties of 
scaffolds, such as surface roughness, have been shown to influence osteoblast 
adhesion, and proliferation. 1 2· 1 3 Polycaprolactone have shown to be hydrolyzed 
by both chemical and biological means. The degradation of PCL-TCP polymers 
by chemical action generally proceeds via a random, bulk hydrolysis of the ester 
bonds in the polymer chain. 14 This process is mainly due to the ends of the 
carboxylic chains that are exposed during the ester hydrolysis. Via a biological 
approach, it was proposed that enzymes, which are soluble in water, would 
first bind to the surface of the PCL-TCP scaffolds and then slowly catalyze the 
hydrolytic scission of polymer chains, resulting in a more rapid breakdown of the 
substrate. 15 
Our strategy is to pre-degrade the PCL-TCP scaffolds before implantation 
in vivo. A chemical and biological degradation method was compared in this 
study to see which would provide scaffolds with suitable surface and physical 
properties for dental use. The present study was aimed at monitoring the in vitro 
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degradation of the scaffolds via NaOH and lipase treatments. The changes in 
surface morphology and physical properties, specifically, weight, molecular 
weight, porosity and mechanical strength, over a period of I 08 hours were recorded 
to determine the optimal approach for the customization of the scaffolds. 
MATERIAL AND METHODS 
Scaffold design and fabrication 
The composite scaffolds were purchased from Osteopore International 
Pte Ltd, Singapore. These scaffolds were fabricated with PCL-TCP (80:20%) 
filaments by using a fused deposition modeling (FOM) 30 Modeler RP system 
from Stratasys Inc (Eden Prairie, MN) and The composites manifested a lay­
down pattern of 0/60/ 120° and porosity of about 70-75 %. The scaffolds were 
produced as blocks of 50 x 50 x 3 mm and specimens of 5 x 5 x 3 mm were used 
throughout the entire experiment. They were then pretreated in 5M NaOH for I 
hour, followed by rinsing three times in Phosphate Buffered Saline (PBS, 137 
mM NaCl, 2.7 mM KC!, 10 mM Na2HPO4, 1.8 mM KH2PO4, pH 7.4) to enhance 
their hydrophilicity. The scaffolds were finally sterilized in 70 % ethanol for 24 
hours, rinsed twice in PBS, and dried in humidified atmosphere at 37 °C and 5 % 
CO2 for I h before used for the experiments. 
Treatment with 3M NaOH or 0. 1 % lipase 
PCL-TCP scaffolds were immersed in 3M NaOH or 0. 1 % lipase solution 
(Sigma, L95 I 8) for a total of I 08 hours at room temperature. Samples were 
recovered at 0, 6, 12, 24, 36, 48, 60, 72, 84, 96 and I 08 hours and evaluated for 
changes in surface morphology (including porosity and rod thickness), molecular 
weight, weight loss and mechanical strength. 
Micro-Computed Tomography (CT) analysis 
The changes in porosities and surface morphologies of the PCL-TCP 
scaffolds after treatment were detected using the SkyScan I 076 in vivo x-ray 
microtomograph system (SkyScan 2002, Belgium). The samples (n = 3) were 
placed on a 35 mm diameter object bed. Before doing a complete scan, a single 
2 dimensional X-ray scout scan was performed to determine the position of the 
scaffolds in the scanning chamber. After which, a complete scan (energy = 104 
KV; intensity = 98 µA; pixel size = 35 µm) was performed. The scanned slices 
were reconstructed using the Cone Beam program. The 3O-Creator program was 
then used to convert the reconstructed dataset into 30 images. Porosity values 
were calculated using the associated CT analyzer software. 
Scanning electron microscopy (SEM) analysis 
Surface morphological changes of the PCL-TCP scaffolds were 
characterized using scanning electron microscopy. The samples were fixed in 2.5 
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% gluteraldehyde (Sigma, Germany) at 4 °C overnight. They were then dehydrated 
in a graded ethanol series of 25 %, 50 %, 75 %, 95 % and I 00 %, air-dried and 
gold-sputtered with JFC-1200 fine-coater for 70 s at 30 mA under high vacuum. 
The specimens were examined with a JEOL JSM 5600LV SEM operating at 10 
kV under high vacuum mode. 
Gravimetric Analysis 
Prior to treatment with NaOH and lipase solutions, the initial weight (W0) of all the specimens was measured. At the respective time periods, specimens 
were removed and blotted dry with a piece of clean tissue paper to get rid of 
excess buffer solution adhering to the surface, weighed and later, dried to constant 
weight in order to determine the weight loss. 
The specimens were dried for 48 hours in an incubator that maintained 
a temperature of 37 °C and controlled humidity of 30 %. The dry weights of the 
3 specimens were then recorded down (W0,). The percent weight loss of the specimens was calculated as follows: 
WO - Wd Weight loss (%) = ry x 1 00% 
WO 
Gel permeation chromatography (GPC) analysis 
The number (M) and weight average (M) molecular weights of the 
scaffolds at the respective time points were determined by gel permeation 
chromatography equipped with an Isocratic HPLC pump (Waters, model 1500 
series), an absorbance detector (Waters, model 2487) and a refractive index 
detector (Waters, model 24 1 4). The samples were first dissolved in HPLC grade 
Tetrahydrofuran (THF) to produce a I % w/v solution. These solutions were then 
filtered using a 0.45µm syringe filter before loading into the GPC columns. GPC 
measurements were carried out at 30°C and at a flow rate of I ml/ min using 
THF as the mobile phase solvent through a Styragel column refractor (Waters). 
Polystyrene standards (Polyscience Co.) ranging from molecular weights of 
275000 to 1200 were used for calibration. 
Mechanical Testing 
The specimens used in both treatment groups measured 5 x 5 x 3 mm. 
The compressive mechanical properties of PCL-TCP scaffolds were determined 
using the Instron 3345 mechanical testing machine with a I KN load cell. Five wet 
sample scaffolds at each time point were tested. The scaffolds were compressed 
at a crosshead speed of I mm/min for up to 80 % of the scaffolds total thickness 
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at room temperature. The mechanical results of load and extension were used to 
calculate the cr, Compressive Stress (MPa) = [Load (N) / Area (m2)] x ( 1  x 10·6) ;  e, 
Strain = Extension (mm) / Original Length (mm); and E, Elastic Modulus (MPa) 
= Compressive Stress (MPa) / Strain. A stress-strain curve was then plotted using 
the experimental data (load versus deformation) and the compressive modulus 
and strength was recorded for each specimen, with the stiffness being measured 
as the slope of the linear portion of the curve. 
RESULTS 
Micro-CT analysis 
Results from the micro-CT analysis revealed that the interconnected pore 
network and honeycomb-like pattern of triangular pores of the PCL-TCP scaffolds 
were generally preserved throughout the experiment in the NaOH-treated group, 
but not in the lipase-treated group that showed signs of physical disintegration as 
early as 24 hours. Figure I A demonstrates the 3D model of the original scaffold 
at the start of the experiment. Notably, the rates of degradation were different for 
the two treatment groups as evidenced by the 3D images at 1 2  (Figure 1 B  and C), 
24 (Figure 1D and E), 48 (Figure I F  and G) and 96 hours (Figure I H and I). 
5mm 
D 
Figure I: (A) 3D model of original scaffold (75% porojity) at O hour. (B) 3D model of scaffolds 
after 12 hour.1 in 3M NaOH. (C) 3D model of scaffolds after 12 hours in lipase. (D) 
3D model of scaffolds after 24 hours in 3M NaOH. 
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E F 
H 
Figure 1: (E) 3D model of scaffold� after 24 hours ill lipase. (F) 3D model of scaffolds after 48 
hours ill 3M NaOH. (G) 3D model of scaffolds after 48 hours in lipase. (H) 3D 
model of scaffolds after 96 hours in 3M NaOH. (I) 3D model of scaffolds after 96 
hours in lipase. 
As the degradation of the scaffolds progressed, the pore dimensions and 
porosity values increased accordingly. After 108 hours, the increase in porosity 
of lipase- and NaOH-treated scaffolds was 30.3 % (0 hours: 75.6 1 ± 0.09 %, 108 
hours : 98.5 1 ± 0.30 %) and 1 5.6 % (0 hours: 75.6 1 ± 0.09 %, 108 hours: 87.44 ± 
I .  13 % ) respectively. In the lipase-treated group, the pore size dimensions of the 
scaffolds were larger as compared to those in the NaOH-treated group. 80% and 
85% porosities of the PCL-TCP scaffolds were observed at 6 and 12  hours for the 
lipase-treated group and at 12-72 hours and 96 hours respectively for the NaOH­
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Figure 2: Porosity 111em11re111e11t1· of 3M NaOH- mu/ lip(l\e-treated PCL-TCP .1caffolds over time. 
SEM analysis 
Before the start of the experiment, the scaffolds demonstrated a consistent 
interconnected architecture. The TCP was evident as particles distributed on the 
surfaces of the rods giving it a coarse surface texture (Figure 3A). 
A 
Figure 3: (A) SEM images of the PCL-TCP vcaffold (porosity 75%) before treatme11t. 
SEM micrographs of the NaOH-treated scaffolds showed a trend of 
increasing surface roughness with time. Under higher magnification, indentations 
or depressions of microporous dimensions were evident and growing with time. 
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The pore size dimensions were however generally maintained. The narrowing 
of rods and the presence of cracks were only observed on the scaffolds after 72 
hours of NaOH treatment. (Figure 3C) 
B 
C 
Figure 3: (8) SEM images of PCL-TCP scaffold� after 60 hours in 3M NaOH. (C) SEM images of 
PCL-TCP scaffold� after 72 hours in 3M NaOH. 
For the lipase-treated group, SEM results showed a similar trend of 
a progressive surface roughness on the rods of the scaffolds. The pore size 
dimensions increased along with obvious thinning of the rods after just 1 2  hours 
of lipase treatment (Figure 3D). In addition, signs of cracks and distortions were 
evident after 24 hours of treatment. A significant disintegration of the rods of the 





Figure 3: (D) SEM images of PCL-TCP scaffolds after 12 hours in 0. 1% lipase. (E) SEM images 
of PCL-TCP scaffolds after 48 hours in 0. / %  lipase. 
Gravimetric analysis 
There was an increasing trend for the percent weight loss over time 
as depicted in Figure 4. The values obtained demonstrated a considerable loss 
of mass of the scaffolds during the course of the experiment with the lipase­
treated scaffolds displaying a more significant reduction at all time points in the 
experiment, as compared to NaOH-treated scaffolds. In addition, the pattern of 
the rate of weight loss differed significantly in both treatment groups. For the 
lipase-treated group, the rate of weight progressed rapidly before slowing down 
after 36 hours. The NaOH-treated scaffolds, however, showed a more gradual rate 
of weight loss and then increased quickly after 84 hours. At the end of I 08 hours, 
the weight loss recorded for the lipase and NaOH-treated groups were 90.6 ± 5.93 
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GPC analysis 
Values obtained for molecular weight (M) and number (M) are displayed 
in Table 1 .  The M and M values of the NaOH -treated PCL-TCP scaffolds were n w generally maintained throughout the experiment (p > 0.05); in comparison to 
the lipase-treated group, where a significant decrease in the M
0 
and Mw values 
(39.97% and 45.2% respectively, p < 0.05) was recorded only after 96 hours of 
treatment. 
Table 1: 
Hour Hour Hour Hour Hour Hour 
0 1 2  24 48 72 96 
NaOH-Treated PCL-TCP Scaffolds 
M,. (Da) 54,548 54,457 56,575 55,330 59,849 58,940 
M,. (Da) 40,4 1 5  38,0 1 0  42,283 40,090 43,04 1 4 1 ,279 
Lipase-Treated PCL-TCP Scaffolds 
M .. (Da) 54,548 54,49 1 54, 1 80 50,364 54,526 29,337 
M,. (Da) 40,4 1 5  39,763 39,842 34,859 38,529 24,667 
Molecular weight ( Mw) and molecular number (Mn) of 3M Na OH- and 0. 1% lipase­
treated PCL-TCP scaffolds over time 
9 1  
Chaptcr 4 
Mechanical testing 
Figures 5A and 5B show the mechanical properties of the PCL-TCP 
scaffolds before and after treatment over time. Both groups of treated scaffolds 
demonstrated a decreasing trend in compressive strength and modulus, in which 
the lipase-treated scaffolds reported a greater rate of reduction than the NaOH 
ones. The NaOH-treated scaffolds reported a 7 1.8 % (0 hours: 7.88 ± 1.02 MPa, 
I 08 hours: 2.22 ± 0.8 1  MPa) and 67 .9 % (0 hours: 22. 1 ± 4.62 MPa, 108 hours: 
7. 10 ± 3.27 MPa) decrease in compressive strength and modulus respectively 
after I 08 hours. As for the lipase-treated scaffolds, there was complete loss of 
both compressive strength and modulus as early as 60 hours after treatment. A 
I 00% reduction in mechanical properties of the scaffolds was observed after 60 
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treat111ent over ti111e. 
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DISCUSSION 
This research was intended to expand the preliminary work on PCL­
TCP scaffolds as synthetic grafts for guided bone regeneration. When used for 
dentoalveolar applications, scaffolds utilized should possess sufficient structural 
integrity as space fillers and favorable mechanical properties to withstand the 
moderate load-bearing conditions in the oral cavity. In this study, the focus was 
primarily to accelerate the degradation rate of the PCL-TCP scaffolds prior to 
dental implant installation to suit dentoalveolar applications, whilst preserving its 
mechanical properties. 
PCL belong to a family of aliphatic polyesters that include polyglycolide 
(PGA) and polylactide (PLA). PCL based polymers are hydrophobic in nature and 
have shown to degrade completely at a slow rate of around 3-4 years. 1 6• 1 7  This is 
due to the high molecular weight and the slow diffusion rate of water internally 
within the scaffold construct. 1 8 Others have attributed that to the high crystallinity 
values of PCL. 190ur recent study reported on the degradation profile of novel PCL­
TCP scaffolds in an in vitro and in vivo environment. 1 1  The extent of degradation 
of PCL-TCP scaffolds in vivo in the abdomen of rats was greater than in vitro 
immersed in culture growth medium. Although the results reported a significant 
degradation of the PCL-TCP scaffolds in the aggressive in vivo environment, the 
second stage of degradation had not commenced at the end of 6 months. 
We plan to accelerate the degradation of PCL-TCP scaffolds via 
enzymatic and hydrolytic approach. The hydrolytic action of polyesters 
in an alkaline medium is similar to that when water is used. The increase in 
concentration of the hydroxyl ions results in a faster degradation process. 20 The 
breakdown of the NaOH-treated scaffolds was reported to be primarily due to 
surface erosion via a random and bulk hydrolysis of the ester bonds in the PCL 
polymer chain. 2 1 • 22 NaOH solution is a strong alkaline reagent. In a recent study, 
when a high concentration of SM NaOH was used to accelerate the hydrolysis, 
complete weight loss of PCL and PCL-TCP scaffolds occurred at 6 weeks and 
48 hours respectively. 20 A low concentration (3M NaOH) was indicated in our 
study in order to achieve a more controlled and predictable degradation of the 
scaffolds. The aim was to customize the degradation rate of PCL-TCP scaffolds 
with the intent to match a favorable load-bearing profile when implanted in the 
oral cavity. In addition, studies have shown that NaOH treatment can enhance the 
hydrophilicity of poly (lactic-co-glycolic acid) (PLGA) and PCL scaffolds that 
resulted in enhanced cellular attachment and proliferation kinetics. 2 1 • 23 It has been 
suggested that the resultant increase in hydrophilicity is due to the exposure of the 
ends of the carboxylic chains during hydrolysis. 14  We proposed that the increased 
surface roughness resulted from the surface erosion during NaOH treatment may 
also contribute to cell attachment and proliferation. 
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Unlike other members of the aliphatic polymer family, PCL has been 
shown to undergo enzymatic degradation as well. 24· 25 Lipase PS, being the most 
widely investigated enzyme was chosen for the present study. It was reported that 
due to its catalytic property, enzymatic degradation involving lipase action on 
PCL films proceeds very rapidly. 18 It was demonstrated in our preliminary study 
that after 7-8 days of immersion in 0. I %  lipase solution, a complete breakdown 
of the PCL-TCP scaffolds was observed (data not shown). 
The present study clearly demonstrated that when the PCL-TCP scaffolds 
were treated with 0.1 % lipase or 3M NaOH solution, distinct rates of degradation 
were observed. In general, the rate and extent of degradation of the PCL-TCP 
scaffolds after lipase treatment was more significant than in the NaOH -treated 
scaffolds. Early signs of cracks and distortions; and obvious thinning of the 
rods were observed from the SEM micrographs as early as 12-24 hours in the 
lipase-treated group as compared to 60-72 hours when treated with NaOH. It has 
been shown previously that surface roughness affects osteoblast adhesion and 
function. 26· 27 The modified surface roughness that resulted at 80%-85% porosity 
for the NaOH-treated scaffolds was manifested as indentations of microporous 
dimensions. This offers a promising surface topography for bone formation to 
occur. This was in contrast to the scaffolds after lipase treatment, where the 
80%-85% porosity was observed only at 6-12 hours respectively, with a less than 
consistent and an unfavorable surface topography. 
It has been shown that the percentage change in weight loss was related 
to the porosity of the scaffold during degradation. 28 Gravimetric analyses 
determined from scaffolds in both treatment groups reported similar percentage 
of weight loss at 80% and 85% porosity. At 80% porosity, lipase treatment 
resulted in 2 1  % weight loss as compared to 22.33% for NaOH treatment (p > 
0.05). At 85% porosity, scaffolds in the lipase-treated group had 45.1 3% weight 
loss as compared to 39.48% for NaOH treated samples (p > 0.05). Here, the 
small percentage increase of porosity (5% and 10% respectively) but significant 
and similar weight loss in both the l ipase and NaOH-treated groups suggests 
that selective degradation had taken place predominantly on the surfaces of the 
PCL-TCP scaffolds resulting in bulk volume reduction. This was in accordance 
to the results obtained from the GPC analysis, where the molecular weights in 
both treatment groups remained largely unchanged (> 54, 000) when 80% and 
85% porosity were achieved. This implied that the scaffolds were mostly in the 
first stage of degradation (the random scission of the carbon chains) at this stage. 
These findings correlate well with our previous study. 1 1 
Studies have shown that scaffolds with high porosity and large pore 
size dimensions are vital to facilitate the infiltration with new bone and vascular 
94 
CuMomizing the degradation and load-bearing profile of 3D PCL-TCP ;caffold, 
structures. 29· 30 However, it has been shown that scaffolds with a too high porosity 
reported lower mechanical properties. 3 1 • 12 In the current study, we targeted to 
increase the porosity of the PCL-TCP scaffolds while maintaining the pore 
interconnectivity and mechanical strength, with the aim to enhance osteogenesis 
for dentoalveolar reconstruction applications. The results from the mechanical 
testing corresponded with the gravimetric analyses. In general, as the percentage 
weight loss of the scaffolds increased, the mechanical properties declined. The 
rapid rate of percentage weight loss corresponds well to the greater rate of 
reduction of mechanical properties in the lipase-treated scaffolds. In contrast, the 
slower rate of decline of the mechanical properties is attributed to the more gradual 
rate of percentage weight loss. Overall, the change of percentage weight loss and 
mechanical properties of the scaffold was more significant in the lipase treated 
group than in the NaOH treated one. However, when comparing the PCL-TCP 
scaffolds at porosities of 80% and 85%, the compressive strength and compressive 
modulus of the scaffolds were comparable in both treatment groups. The average 
compressive strength in the NaOH-treated group at 80% and 85% measured at 
6.66 MPa and 4.60 MPa respectively and that in the lipase-treated group was 
6. 10 MPa and 4.36 MPa respectively. The values obtained closely matches to 
that of human cancellous bone, 33 which suggest that the pre-degraded PCL-TCP 
scaffolds at 80% and 85% have reasonable mechanical strength to withstand the 
moderate load-bearing forces indicated for dentoalveolar ridge augmentation. 
CONCLUSION 
In conclusion, the pretreatment of PCL-TCP scaffolds with NaOH 
represents a simple approach for tailoring its physical properties and degradation 
rate to suit dentoalveolar applications. Our study showed that the extent and 
rate of degradation for the lipase-treated PCL-TCP scaffolds was significantly 
greater than the NaOH-treated group at their corresponding time points as the 
experiment progressed. A distinct advantage the NaOH-treated group had over 
the lipase-treated group was the more favorable surface topography that resulted 
and the increase in the hydrophilic nature of the scaffolds, though the physical 
and mechanical properties at 80% and 85% porosity were comparable. Future 
work entails investigating the efficacy of the NaOH-treated PCL-TCP scaffolds 
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ABSTRACT 
Pre-treatment of polycaprolactone-20% tricalcium phosphate (PCL-TCP) 
scaffolds under alkaline conditions can be utilized to alter surface characteristics 
for enhanced early bone formation. PCL-TCP scaffolds were treated with sodium 
hydroxide (NaOH) at various time intervals (group A: Untreated, group B: 3M 
NaOH for 48 hours and group C: 3M NaOH for 96 hours). In vitro results showed 
a greater degree of physical changes in the NaOH treated scaffolds (B and C) than 
the untreated group (A). Clearly, the NaOH treated scaffolds showed an increased 
surface roughness than the untreated ones. A significantly large number of 
'channel-like' pits and greater average pit sizes were detected in groups B ( 14.5 1 
± 10.9 µm) and C (20.27 ± 14.3 µm); and absent in group A. In addition, treated 
scaffolds had a significant reduction of the water contact angle (40.9-58.2 %). 
Favorably, the pore dimensions and scaffold rod thickness remained unchanged 
throughout the experiment. When implanted in the calvaria of rabbits, NaOH 
treated scaffolds reported greater early matrix deposition and bone formation from 
scanning electron images and microCT analyses. In conclusion, pretreatment of 
PCL-TCP scaffolds with NaOH increases the wettability and surface area for 
initial matrix deposition and early bone ingrowth. 
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The use of scaffolds plays an important role in bone tissue engineering 
applications. They serve as temporary space fillers within anatomic deformities, 
whilst providing initial mechanical support necessary for early bone regeneration 
to occur. 1 . 2 
It has been reported that cellular adhesion and proliferation are closely dependent 
on the topographical nature of the biomaterial surface. 3 Studies have shown that 
an increase in surface area or roughness of scaffold matrices enhances osteoblast 
response, which can lead to an improved osteoconductivity of the biomaterial. 4• 
5 A novel three-dimensional (3D) bioresorbable scaffold consisting of 80% PCL 
and 20% TCP is used in our study. These scaffolds possess an ideal interconnected 
pore network and are highly reproducible via a fused deposition modeling 
technique. In addition, they have been studied extensively in vitro and in vivo for 
bone tissue engineering applications. 6• 7 
Our group plans to focus the use of the PCL-TCP scaffolds for 
dentoalveolar reconstruction purposes. Traditionally, PCL-based scaffolds tend 
to degrade at a slow rate. 8· 9 Scaffolds utilized for alveolar ridge augmentation 
should degrade predictably over an optimal period of 5-6 months whilst allowing 
new bone formation and bone replacement to occur accordingly. This is to ensure 
that dental implants can be inserted later within the newly regenerated bone for 
prosthetic rehabilitation to take place. Our study plans to develop a customized 
3-D PCL-TCP scaffold with a favorable degradation profile and desirable 
topographical and surface characteristics. Our earlier experiment investigated 
the degradation profile of PCL-TCP scaffolds in vitro and in vivo. Even when 
implanted in an aggressive environment of the rats' abdomen, 88.7% reduction 
of molecular weight-average of the scaffolds still remained after 6 months. 10 It 
has been proposed that a smaller particle size and a larger pore configuration, 
through a greater surface area encourages more rapid bioabsorption and enhanced 
osteogenesis. 1 1  
An enzymatic and alkaline degradation study was recently conducted by 
our team to evaluate the pretreatment method that would provide the modified 
scaffolds with a suitable surface and physical properties tailored for dentoalveolar 
regeneration use. The aim was to customize the degradation rate of PCL-TCP 
scaffolds with the intent to match a favorable load-bearing profile. Data from 
the resultant weight loss, porosity value changes and load-bearing properties 
clearly demonstrated superior results obtained from the NaOH treated group. 
1 2  In the present study, our strategy was to modify the PCL-TCP scaffolds by 
Na OH pretreatment with the intention of altering the surface characteristics of the 
scaffold rods. Results from our in vitro study focused on the alterations in surface 
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characteristics, hydrophilicity, pore morphology and structural architecture of 
PCL-TCP scaffolds when treated with NaOH under varying time intervals. Results 
from the in vivo experiments analyzed early matrix and cellular deposition on the 
scaffold rods; and initial bone formation within the scaffold system. 
MATERIALS AND METHODS 
Ill vitro charact erization study 
Scaffold Fabrication 
Scaffold specimens were fabricated with PCL- 20% TCP filaments 
using a fused deposition modeling (FDM) 3D Modeler RP system from 
Stratasys Inc (Eden Prairie, MN). Blocks of 50 x 50 x 2mm were created 
directly in Stratasys Quickslice (QS) software. They were directly purchased 
from Osteopore International Pte Ltd, Singapore. A lay-down pattern of 
0/60/ 120° was used to give a honey-comb-like pattern of triangular pores with 
a porosity of 75 %. The specimens were then cut into smaller discs of 6mm in 
diameter and 2mm in thickness. (Figure I )  
Figure 1 :  PCL-TCP scaffold .1pecime11 measuring 6mm i11 diameter and 2111111 i11 thickness 
Study design and alkaline treatment of scaffolds 
Three groups of PCL-TCP scaffolds were analyzed: 
A. Untreated 
B. 3 mo)L· 1 (3M) NaOH treated/ 48 hours 
C. 3 moJL- 1 (3M) NaOH treated/ 96 hours 
PCL-TCP scaffolds in the treated groups B and C were immersed in 
phosphate buffer saline (PBS, 137 mM NaCl, 2 .7 mM KCL, 10 mM Na2HPO4, 
1.8 mM KH2PO4, pH 7.4) for two hours followed by immersion into 3M NaOH 
for 48 and 96 hours at 37 °C respectively. The treated scaffolds are then removed 
and rinsed in PBS three times. 
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Scanning electron microscope (SEM) analysis 
Surface morphological changes of the PCL-TCP scaffolds were 
characterized using scanning electron microscopy. The samples were fixed 
in 2.5 % gluteraldehyde (Sigma, Germany) at 4 °C overnight. They were then 
dehydrated in a graded ethanol series of 25 % (5 min), 50 % ( 10 min), 75 % ( 10 
min), 95 % ( !Omin) and 100 % ( I O  min, 3 times), air-dried and gold-sputtered 
with JFC-1200 fine-coater for 40 s at 10 mA under high vacuum. The specimens 
were examined with a JEOL JSM 5600LV SEM operating at 15 k V  under high 
vacuum mode. 
Micro-computed tomography (Micro-CT) analysis 
Native untreated and NaOH treated scaffolds were isotropically scanned 
at 1 4-µm resolution with an SMX-1 00CT micro-CT scanner (Shimadzu, Japan) 
using a coneCT scanning technique. To ensure a consistent CT image resolution 
among all the datasets, the scanner turntable location was fixed at a specific SOD 
(48.03 mm) and SID (361.30 mm) respectively. X-ray parameters were set at 
33 kV and 156 µA and the CT images were processed at a scaling coefficient of 
100 and averaged 3 times. Resultant micro-CT datasets for each bone cube were 
evaluated for microarchitectural parameters using CTan software (Aartselaar, 
Belgium). Parameters such as bone specific surface (BS/BY), trabecular (rod) 
thickness (Tb.Th) are analyzed. 
Water contact angle testing 
Water contact angles were measured using video contact angle 
goniometer (Advanced Surface Technology, USA), which relies on sessile drop 
technique. To ensure consistency, the volume of water droplet at each dispensing 
was maintained at 0.03 µI and each measurement was taken 5 s after dispensing. 
Another parameter that was kept constant includes medium speed for drop 
delivery. For every sample, 10 measurements were obtained at different regions 
and the mean average calculated. 
In vivo charact erization study 
Experimental Design 
The second part of the study continues to evaluate the similar groups of 
untreated and NaOH treated PCL-TCP scaffolds when implanted in the calvaria 
of rabbits. The scaffolds were randomly assigned to the defects made in the 
calvaria of rabbits and followed up for 2, 4 and 8 weeks. Micro-CT and SEM 
analyses were performed to investigate the effects on early matrix deposition and 
bone formation. 
Fifteen, 6-8 month old New Zealand White male rabbits were used for 
the in vivo experiments. The study was approved by the SingHealth Institutional 
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Animal Care and Use Committee (IACUC) and conformed to the respective 
guidelines. The rabbits were operated on under general anesthesia, which consisted 
of an intraperitoneal injection of ketamine and xylazine mixture (75 mg/kg + 10 
mg/kg). Once the soft tissue and periosteum were carefully elevated and reflected, 
with constant saline irrigation, 6 mm diameter circular and 2 mm deep defects 
were made using the appropriate trephine drills. Defects are randomly assigned 
to receive 1 of the 3 test scaffolds (Figure 2). Prior closure, a non-resorbable 
membrane will be positioned over the defects to prevent soft tissue ingrowth. The 
periosteum will be repositioned to cover the scaffolds followed by closure of the 
skin with sutures. The rabbits will be given carpofen ( 1-2 mg/ kg) and cephalexin 
( 15-20 mg/ kg) subcutaneously for 3 and 5 days respectively. At sacrifice, 5 
rabbits were euthanized at 2, 4 and 8 weeks respectively. The tissues surrounding 
the selected implanted scaffolds were carefully removed and wrapped in PBS­
soaked gauze and subsequently subjected for micro-CT (n = 4) and SEM (n = l )  
analyses. 
Figure 2: Implanted scaffo/dJ within the assigned defects ill the calvaria of a rabbit 
Alkaline treatment and sterilization 
PCL-TCP scaffolds were immersed in PBS for two hours followed by 
immersion into 3M NaOH for 48 and 96 hours at 37 °C for groups B and C 
respectively. The treated scaffolds are then removed and rinsed in PBS three 
times. The scaffolds are then sterilized in 70 % ethanol for 24 hours. This is 
followed by rinsing twice with in PBS with centrifugation at I 000 rpm for I 0 
min. The scaffolds are dried in humidified atmosphere at 37 °C and 5 % CO2 for 
I hour and soaked for 3 hours in PBS. 
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Native and NaOH treated scaffolds were being isotropically scanned at 
14 µm resolution with an SMX- IO0CT micro-CT scanner (Shimadzu, Japan) 
using a cone CT scanning technique. To ensure a consistent CT image resolution 
among all the datasets, the scanner turntable location was fixed at a specific SOD 
(48.03 mm) and SID (361.30 mm) respectively. X-ray parameters were set at 33 
kV and 156 µA and the CT images were processed at a scaling coefficient of 100 
and averaged 3 times. Region of interest (6 mm diameter) was drawn at the site 
of implantation. Resultant micro-CT datasets for each bone cube were evaluated 
for microarchitectural parameters using VG Studio Max software (Heidelberg, 
Germany). Parameters such as new bone formation, scaffold and void volumes 
are obtained and analyzed. 
SEM analysis 
Surface morphological changes of the PCL-TCP scaffolds were 
characterized using scanning electron microscopy. The samples were fixed 
in 2.5 % gluteraldehyde (Sigma, Germany) at 4 °C overnight. They were then 
dehydrated in a graded ethanol series of 25 % (5 min), 50 % ( I O  min), 75 % ( l  0 
min), 95 % ( I Omin) and 100 % ( I O  min, 3 times), air-dried and gold-sputtered 
with JFC-1200 fine-coater for 40 s at 10 mA under high vacuum. The specimens 
were examined with a JEOL JSM 5600LV SEM operating at 15 k V  under high 
vacuum mode. 
Statistical Analysis 
The pits' dimensions, water contact angles and scaffolds microarchitectural 
parameters (in vitro) and early bone formation (in vivo) were presented as mean 
values ± standard deviation (SD) of the mean. Data analyses and comparisons were 
performed using one tailed Student's paired t-test (Microsoft Excel). P-values of 
< 0. 1 were considered as statistical significance. 
RESULTS 
/11 vitro charact erization study 
Scanning Electron Microscope {SEM) analysis 
Figures 3a (A-C) illustrated SEM images of untreated and NaOH treated 
PCL-TCP scaffolds under high magnification. A relatively smooth surface of 
the untreated PCL-TCP scaffold with uniformly distributed TCP particles was 
observed in Figure 3A. Indentations or pits were apparent in the NaOH treated 
scaffolds as shown in Figures 3 (B and C). Generally, results from the scanning 
electron images showed that there was an increase in the surface roughness of the 
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Figure 3a: SEM image.1 of PCL-TCP scaffolds of different NaOH treatment giv11ps with TCP 
particles encircled (A) Untreated (B) 3M NaOH treated/ 48 /11: Appearance of 
11umero11s pits and i11delltatio11s can be observed 011 the scaffold rods. (C) 3M NaOH 
treated/96 111: Appearance of 1111111ero11.1 pits and i11de11tatio11.1· can be observed on the 
scaffold rods 
The average dimensions of pits on the rods of scaffolds from the test 
groups were determined from SEM images. A standard 'tic-tac-toe' grid (as 
shown in Figure 3a) was randomly dropped on the SEM images for a total of 
three counts. All pits in contact with the grid lines were identified. The average of 
2 perpendicular maximum pit widths for each pit size was measured. The number 
of pits counted and their respective dimensions were then calculated. The average 
pit size for group B and C are summarized in Table I .  After 48 hours of 3M NaOH 
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treatment, the average pit size was recorded as 14.51 ± 10.9 µm. It increased by 
39.7% to 20.27 ± 14.3 µm after 96 hours of 3M NaOH treatment. In contrast, the 
number of pits counted decreased from 39 to 26 respectively. 
Table 1:  
Treatment group No of counts (n) Average pit size (µm) 
B (3M NaOH/ 48 hr) 39 1 4.5 1 ± 1 0.9 
C (3M NaOH/ 96 hr) 26 20.27 ± 1 4.3 
Average pit size and numbers on PCL-TCP scaffold rods of different NaOH treatment 
groups 
Cross-sectional representations of untreated and NaOH treated PCL­
TCP scaffolds rods are shown in the diagrams below (Figure 3b). The presence of 
uniformly distributed TCP particles displays a gradual undulating appearance on 
the rods of the untreated scaffolds as compared to the exaggerated 'tunnel-like' 
indentations in the treated groups. Clearly, the surface area to volume ratio of the 




Cross-sectional representation of a PCL-TCP scaffold rod before and after NaOH 
treatment (A) Untreated. Appearance of evenly distributed 'bumps ' of TCP particles is 
illustrated. (B) 3M NaOH treated ( 48 and 96 hr). Appearance of multiple 'channel-like ' 
pits is illustrated. 
Micro-CT analysis 
Results from the micro-CT analysis revealed that the honeycomb-like 
pattern of the interconnected pore network within the PCL-TCP scaffolds was 
generally maintained throughout the varying exposures to NaOH treatment 
(Figures 4(A-C)). The brighter white spots represented TCP particles on the rods 
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of the scaffolds. The micro-CT images confirmed that a uniform distribution 
of TCP particles was demonstrated after 48 and 96 hours of NaOH treatment 
(Figures B and C). 
Figure 4: 
6 mm 
Micro-CT images of PCL-TCP scaffolds of different NaOH treatment groups. The 
uniformly di.\tributed white specks 011 the scaffold rods represelll TCP particles. (A) 
Untreated (B) 3M NaOH treated/ 48 hr (C) 3M NaOH treated/ 96 hr 
Mean rod thickness and mean pore separation were unaffected 48 and 96 
hours after Na OH treatment as shown in Figure 5. This was shown by the consistent 
mean rod thickness of the treated scaffolds (groups B and C) as compared to 
the untreated scaffolds (group A). Similarly, the mean pore separation remained 
largely unchanged throughout the experiment. Results suggest that the surface 
alterations that primarily occurred on the scaffold rods after 48 and 96 hours of 
NaOH treatment did not affect the overall structural architecture and framework 
of the PCL-TCP scaffolds. 
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Mean rod thicknen and mean pore separation of different NaOH treatment groups 
Water Contact Angle Testing 
Contact angle in this report was defined as the angle formed by the 
intersection of two tangent lines to the liquid and solid surfaces at the perimeter 
of contact between the two phases and the third surrounding phase. Diagrammatic 
representations of the contact angles of both untreated (group A) and treated 
(groups B and C) scaffolds are shown in Figure 6. In addition, Figure 7 illustrates 
the water contact angle of the scaffolds under varying NaOH treatment exposures. 
Untreated PCL-TCP scaffolds reported a high water contact angle of 9 1.2 ± 8.8°. 
When treated with NaOH, a greater percentage reduction of the water contact 




SEM images of PCL-TCP scaffolds showing their respective contact angles of 
different NaOH treatment groupJ. (A) Untreated (B) 3M NaOH treatecl/ 48 hr (C) 
3M NaOH treatecl/ 96 hr 
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NaOH treatment g roups (hours ) 
Wllter co11tllct llngle 111el1sureme11ts of different NaOH trelltment group.I. Data are 
shown as 111ea11 ± SD. ( ) i11dicllte.1 statistical .1ig11ijica11t 111em1 wllfer contact angle 
(p < 0.05) between untreated and NaOH treated .1·cciffolds. 
Ill vivo characterization study 
SEM analysis 
SEM analysis revealed that the untreated PCL-TCP scaffold composed 
of a regular arrangement of composite rods with a highly interconnected pore 
network consisting of TCP particles distributed across the surface of the scaffold. 
The general architecture and surface morphology of the PCL-TCP scaffolds are 
illustrated under both low and high magnifications as shown in Figure 8a. 
(8 
Figure Ba: SEM inwges of untreated PCL-TCP scaffold specimem. (A) 25X 111agnificatio11 (B) 
JOOX mllgnificatio11 
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Images from SEM taken after 2 weeks of scaffold implantation 
demonstrated initial cell attachment and extracellular matrix (ECM) deposition 
across the scaffold rods. The appearance of an increasing trend cell attachment 
and distribution of ECM is clearly visible and intense after 4 and 8 weeks. In 
addition, it is obvious that the NaOH treated scaffolds displayed a greater degree 
of cellular and matrix-interaction with the composite rods as compared to the 
untreated PCL-TCP scaffold (Figures 8b, 8c and 8d). 
Figure 8b : SEM images of PCL-TCP scaffold Jpecimens of differelll NaOH 1rea1111elll group.1 
af1er 2 weeh of i111plm11a1io11. (A) Ulllreated (8) 3M NaOH trealedl 48 hr (C) 3M 
NaOH lrealed/ 96 hr 




SEM images of PCL-TCP scaffold specimem of different NaOH treatment groups 
after 4 weeks of impla11tatio11. (A) Untreated (B) 3M NaOH treated/ 48 hr (C) 3M 
NaOH treated/ 96 hr 
Figure 8d: SEM images of PCL-TCP .1caffo/d specimens of different NaOH treatmelll groups 
after 8 weeks of i111pla11tatio11. (A) Umreated (B) 3M NaOH treated/ 48 hr (C) 3M 
NaOH treated/ 96 hr 
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Micro-CT analysis 
Micro-CT was utilized to determine the value of early bone volume 
ingrowth detected at the 2, 4 and 8 weeks after implantation of the scaffolds (Figure 
9). Early results of new bone formation from 2-8 weeks showed an increasing 
trend in the volume of bone ingrowth when PCL-TCP scaffolds are pretreated 
with NaOH. Across the 3 treatment groups, the volume of new bone formation 
reported similar findings at 2 weeks (Group A: 7.22 mm3, B: 7.39 mm3 , C: 7.56 
mm3).  This is followed by an increase in bone volume after 4 and 8 weeks, where 
groups B (4 weeks: 15.76 mm3 ; 8 weeks: 23. 1 1 mm3) and C (4 weeks: 17.2 1 mm3 ; 
8 weeks: 2 1.47 mm3) reported the most significant improvements as compared to 
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Resultallf new bone volume detected ftvm defect sites of differellf NaOH treatment 
g,vups using Micm-CT analyses after 2, 4 and 8 weeks of implallfation. Data are 
shown as mean ± SD. (1) indicates statistical significant mean new bone volume (p 
< 0. 1)  between untreated and NaOH treated scaffolds at 8 weeks. 
DISCUSSION 
The current research was a continuation of earlier studies in which the 
degradation profiles of PCL-TCP scaffolds were investigated. 10• 1 2 The objectives 
of this study is a) to characterize the surface and structural properties of PCL­
TCP scaffolds when treated with NaOH at various exposure intervals and b) to 
investigate the effects of surface modification of the scaffolds influencing early in 
vivo bone formation. 
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There has been growing interest to investigate cellular responses on 
surface topography and characteristics of biomaterials. Surface properties of 
scaffolds, such as surface roughness, had been shown to influence osteoblast 
adhesion, and proliferation. 1 3· 14 Alkaline treatment is a straightforward way on 
improving the surface hydrophilicity of scaffolds by increasing the hydrophilic 
terminal groups (carboxyl and hydroxyl groups) on the rods surface. 15 In another 
study, vascular endothelial and smooth muscle cells demonstrated better adhesion 
and enhanced proliferation when NaOH was utilized to modify PCL films. In 
addition, there were no reports of cytotoxic effects from the alkaline treatment. 1 6  
The degradation of PCL and PCL-TCP scaffolds has been studied in an alkaline 
medium. 5 molL 1 (SM) NaOH was used to accelerate the hydrolytic process. 
Complete degradation was achieved in 6 weeks and 54 hours for the PCL and 
PCL-TCP scaffolds respectively. 1 7  A lower concentration of 3 molL· 1 (3M) 
NaOH was chosen for the current study in order to achieve a more controlled 
and predictable surface alteration of the scaffolds. The primary objective was to 
improve the surface characteristics of the scaffold rods and secondly to accelerate 
the degradation rate of PCL-TCP scaffolds to allow for a faster ingrowth of 
new bone prior dental implants insertion in dentoalveolar applications. In our 
recent study, we showed that pretreatment of PCL-TCP scaffolds with NaOH 
demonstrated a simple approach for modifying the degradation rate whilst tailoring 
its mechanical properties to withstand the moderate load-bearing conditions. 1 2 
Our study clearly demonstrates that when PCL-TCP scaffolds are treated 
with 3M NaOH, surface alterations occurred which further enhanced the scaffold 
wettability and increased surface area to volume ratio of the rods. This serves 
as an advantage as early studies have shown that osteogenic cells showed lower 
proliferative and higher apoptotic rates on polymers with hydrophobic surfaces 
compared to hydrophilic ones. Increasing surface roughness would inversely 
decrease the water contact angle and hence improve the hydrophilicity of the 
biomaterial. 3• 15 In our study, we reported a high water contact angle of 9 1.2 ± 8.8° 
in scaffolds that were untreated. When treated with NaOH, a significant reduction 
of the water contact angle of was reported in groups B (58.2 %) and C (40.9 %), 
rendering the PCL-TCP scaffolds more hydrophilic in nature. 
In the present study, pores are defined as the regular network of voids 
within the framework of the scaffold. Pits are the indentations or micro-cavities 
on the rods surface of a scaffold that result from NaOH pretreatment. Particle and 
pore size geometry are important characteristics of any scaffold or biomaterial. 
18  It has been proposed that a smaller particle size and a larger pore configuration 
encouraged more rapid bioabsorption and enhanced osteogenesis through a 
greater surface area. 18 Results from a study suggested that a minimum pore size 
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of I 00µm is necessary to achieve favorable vascularization and bone formation. 
The optimal particle size should also be 300-S00µm. 20 The pore geometry of our 
lab's fabricated PCL-TCP scaffolds measure 400-600µm and a rod diameter of 
approximately 250µm. 2 1 · 22 Our results showed that the scaffold architecture and 
pore morphology, which was measured as mean rod thickness and mean pore 
separation respectively, remained constant throughout the in vitro experiment. A 
greater number and size of micro pits were however detected in NaOH treated 
groups as compared to the untreated scaffolds. Interestingly, these treated 
scaffolds displayed an appearance of enhanced 'channel-like' indentations, which 
significantly increases the surface area to volume ratio of the scaffolds for matrix 
deposition and cellular attachment. A greater bone-polymer interaction would 
eventually occur and promote a superior interfacial mechanical interlock, whilst 
healing and early bone tissue remodeling may take place under load bearing 
conditions. 
As it was a concern that the TCP particles on the surface of the scaffolds 
would be dislodged after NaOH treatment, we proceeded to determine the 
possible effects of the later. Results from micro-CT and SEM images confirmed 
that a uniform distribution of TCP particles was still demonstrated after 48 and 96 
hours of NaOH treatment. In addition, material chemical analysis measured the 
percentage composition of tricalcium phosphate on untreated and NaOH treated 
PCL-TCP scaffolds. Results reported a 4.39 % and 15.56 % reduction of TCP 
content after 48 and 96 hours NaOH treatment respectively (unpublished data). 
Overall, this is in line with our strategy where we planned to perform selective 
modification on PCL-TCP scaffolds without involving significantly the physical 
and mechanical properties. 
The second part of the study was to investigate the in vivo behavior of early 
matrix deposition and early bone formation of PCL-TCP scaffolds in the calavria 
of rabbits after 2, 4 and 8 weeks of implantation. Throughout the experiment, all 
the scaffolds that were implanted within the assigned defects remained in-situ 
with no signs of migration. The survival rate of the rabbits was excellent and 
they healed and recovered well after the surgeries. There were no reports of any 
complications detected, such as overt edema and infection during the healing 
period, suggesting that the additional series of rinsing and sterilization following 
NaOH treatment of the PCL-TCP scaffolds assisted in promoting a conducive in 
vivo environment for healing to take place. 
ECM represents a complex substrate composition of both structural and 
functional molecules arranged in a three dimensional network. 23 The ECM serves 
various functions including maintaining tissue integrity and homeostasis; and 
facilitating cell attachment, proliferation and differentiation. 24 This is essential 
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for the physiologic processes of growth and wound healing to occur. Studie have 
shown that greater osteoblast adhesion and function; and increased levels ECM 
proteins were demonstrated on surfaces with higher surface roughness. 25• 26· 27 It is 
clearly seen from the SEM images that after 2 weeks of implantation, there was an 
increased early ECM deposition and cell attachment on the surface of the NaOH 
treated PCL-TCP scaffolds at 4 and 8 weeks as compared to the untreated ones. 
Micro-CT analyses confirmed our SEM findings in which the volume of new 
bone fonnation detected remained similar 2 weeks after implantation; however, 
the NaOH treated scaffolds demonstrated much improved bone formation after 4 
and 8 weeks. Overall, groups B (4 weeks: 1 1 3 .4 %;  8 weeks: 2 1 2.9 %) and C (4 
weeks: 1 27 .6 %; 8 weeks: 1 84. 1 % ) reported the most significant improvements 
in early bone formation as compared to group A (4 weeks: 98.8 % ;  8 week : 1 26.6 
% ). The results suggest that an increase of surface roughness on the scaffolds rods 
largely influence the extent of early new bone formation. 
CONCLUSION 
PCL-TCP scaffolds that were treated with 3M NaOH for 48 and 96 
hours demonstrated selective modification of the surface characteristics without 
significantly affecting the physical and mechanical properties. When implanted 
in the calvaria of rabbits, these scaffolds displayed encouraging results when 
early new bone formation was analyzed. Additional studies are being conducted 
to further investigate the effects of porosity changes and increased surface 
roughness on the degradation profile of NaOH treated PCL-TCP scaffolds when 
implanted in vivo in the calvaria of rabbits. We are targeting to develop a scaffold 
with improved surface properties and favorable degradation profile used for 
dentoalveolar reconstruction applications. 
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ABSTRACT 
Traditionally, polycaprolactone (PCL) based scaffolds tend to degrade 
at a slow rate. Pre-treatment of polycaprolactone-20% tricalcium phosphate 
(PCL-TCP) scaffolds under alkaline conditions can be utilized to increase the 
degradation rate and improve mechanical properties. 3 groups of PCL-TCP 
scaffolds with varying pretreatment exposures with sodium hydroxide (NaOH) 
were studied in a rabbit calvaria defect model and analyzed at 2, 4, 8, 1 2  and 24 
weeks. (Group A: Untreated, Group B: 3M NaOH/ 48 hours and Group C: 3M 
NaOH/ 96 hours). Micro-CT analysis demonstrated that scaffolds with increased 
surface roughness (Groups B and C) showed a greater impact on the overall 
volume loss during the early healing period between 2 to 8 weeks as compared to 
the untreated group. In addition, greater bone formation was detected in NaOH 
treated scaffolds as compared to the untreated group throughout the experiment. 
Scaffolds with increased surface roughness generally reported higher push out test 
and compressive strength values from 4 to 8 weeks of early healing. Interestingly, 
the mechanical properties displayed a decline in values from 1 2  weeks onwards 
in the modified groups suggesting a favourable breakdown or weakening of PCL­
TCP scaffolds tailored for replacement by new bone formation. 
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INTRODUCTION 
PCL-TCP scaffolds have been extensively studied and demonstrated 
excellent results in bone tissue engineering applications. 1 ·6 Previous studies have 
shown that these scaffolds with 70-75% porosity values possess many of the 
desired characteristics for use as a biodegradable scaffold; however due to the 
high molecular weight and hydrophobic nature, polycaprolactone-based scaffolds 
generally tend to degrade at a slow rate. 7• 8 When indicated for dentoalveolar 
reconstruction, scaffolds should degrade predictably over an optimal period of 5-6 
months whilst maintaining structural support and allowing new bone formation to 
occur and replace accordingly. 9• 10 This is often followed by the insertion of dental 
implants and thereafter a final dental prosthesis. 
There has been an increasing trend for researchers to modify the surface 
characteristics and architecture of scaffolds used for tissue engineering. It has 
been shown that improved osteoconductivity of a biomaterial could be achieved if 
the microstructure roughness could be enhanced. 1 1 . 1 2  Greater osteoblast adhesion 
and function and increased levels extracellular matrix proteins were reported on 
surfaces with higher surface roughness. 13• 14• 15 Particle and pore size geometry are 
important characteristics of any scaffold or biomaterial. 8 It has been proposed 
that a smaller particle size and a larger pore configuration encouraged more 
rapid bioabsorption and enhanced osteogenesis through a greater surface area. 
16 A recent study investigated the effects of scaffold surface characteristics on 
stem cell performance. Results showed conclusively that scaffold with increased 
surface roughness in the form of microcavities, exhibited a more robust osteogenic 
response as compared to smooth surface scaffolds. 1 7  
Our group has been actively testing and customizing a novel bioresorbable 
scaffold (80% PCL: 20% TCP) targeted for dentoalveolar applications. Earlier, 
we reported on the degradation profile of novel PCL-TCP scaffolds in an in vitro 
and in vivo environment. Although the degradation rate was accelerated with the 
addition of TCP particles, it was however still unfavorable after 6 months. 18 It 
had been demonstrated that our lab's fabricated PCL-TCP scaffolds produced 
favorable pore geometry of 400-600 µm and rod diameter of approximately 250 
µm. 19• 20 Our team proceeded to modify the PCL-TCP scaffolds with the intent 
to further increase the degradation rate and improve the surface characteristics 
by pretreating with lipase and sodium hydroxide (NaOH). Findings from our 
previous study reported that pretreatment of PCL-TCP scaffolds with NaOH can 
be used to improve surface characteristics, which can be tailored to encourage 
a more rapid degradation rate and in tum enhance early bone formation. In 
addition, these modified scaffolds were shown to retain favorable mechanical 
properties essential in withstanding moderate load-bearing forces, such as intra-
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oral dentoalveolar applications. 21 Scanning electron images (SEM) and micro­
computed tomography (micro-CT) results obtained from our most recent study 
demonstrated improved wettability of PCL-TCP scaffolds when treated with 
NaOH. This improved hydrophilicity of the treated scaffolds resulted in greater 
initial matrix deposition and promoted early bone ingrowth. A greater number 
and size of micro pits with 'channel-like' indentations were detected after 
NaOH treatment. Interestingly, it did not affect the overall pore dimensions and 
interconnected honeycomb architecture even after 48 and 96 hours of NaOH 
treatment. 22 
The aim of the present study was to investigate the effects of increased 
surface roughness of PCL-TCP scaffolds on the degradation profile, mechanical 
properties and new bone formation in a rabbit calvaria defect model over a period 
of 6 months. Mechanical analyses, such as compression and push out testing 
were performed to evaluate the overall strength of the newly regenerated bone 
within the scaffold and the interfacial shear strength at the bone-scaffold interface 
respectively. The extent of loss of scaffold volume, new bone formation and the 
healing patterns were determined using micro-CT and histology analyses. 
MATERIALS AND METHODS 
Scaffold Fabrication 
Scaffold specimens were fabricated with PCL- 20% TCP filaments using 
a fused deposition modeling (FDM) 3D Modeler RP system from Stratasys Inc 
(Eden Prairie, MN). Blocks of 50 x 50 x 2mm were created directly in Stratasys 
Quickslice (QS) software. They were directly purchased from Osteopore 
International Pte Ltd, Singapore. A lay-down pattern of 0/60/120° was used to 
give a honey-comb-like pattern of triangular pores with a porosity of 75%. The 
specimens were then cut into smaller discs of 6mm in diameter and 2mm in 
thickness. 
Study design and alkaline treatment of scaffolds 
Three groups of PCL-TCP scaffolds were analyzed: 
A Untreated 
A 3 molL· 1 (3M) NaOH treated/ 48 hours 
A 3 moJL- 1 (3M) NaOH treated/ 96 hours 
PCL-TCP scaffolds in the treated groups B and C were immersed in 
phosphate buffer saline (PBS, 137 mM NaCl, 2.7 mM KCL, IO  mM Na2HPO4, 1.8 mM KH2PO4, pH 7.4) for two hours followed by immersion into 3M NaOH for 48 and 96 hours at 37°C respectively. The treated scaffolds were then removed 
and rinsed in PBS three times. Scanning electron micrograph (SEM) images of 
NaOH treated PCL-TCP scaffolds at various time intervals are shown in Figure I .  
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(B) (C) 
SEM images of PCL-TCP scaffolds treated with NaOHfor (A) 0 hours (B) 48 hours 
(C) 96 hours 
Experimental Design 
The scaffolds were randomly assigned to the defects made in the calvaria 
of rabbits and followed up for 2, 4, 8, 1 2  and 24 weeks. Micro-CT, mechanical 
strength testing (compressive strength and push out test), histology analyses were 
performed. A minimum of 1 1  samples are required for each experimental group 
at 2 weeks, 4 weeks ( 1  month), 8 weeks (2 months), 12 weeks (3 months) and 
24 weeks (6 months) time points respectively to have sufficient data for analysis 
as recommended by ISO standard 10993-6. Since we had a total of 33 samples 
at each time point and 3 samples were implanted in each rabbit, 55 rabbits were 
needed for the entire study. 
Animal husbandry and scaffold implantation 
Fifty-five, 6-8 month old New Zealand White male rabbits were used. 
The study was approved by the SingHealth Institutional Animal Care and Use 
Committee (IACUC) and conformed to the respective guidelines. The rabbits 
were operated on under general anesthesia, which consisted of an intraperitoneal 
injection of ketamine and xylazine mixture (75 mg/ kg + 10 mg/ kg). Under 
anesthesia, the skull region of the rabbit was shaved and scrubbed with iodine, 
followed by disinfection with 70 % ethyl alcohol. 
A midline incision was made in the skin of the calvaria along the sagittal 
suture line. The soft tissue and periosteum are elevated and reflected. Under 
constant saline irrigation, 6 mm diameter circular and 2 mm deep defects were 
made using the appropriate trephine drills. A total of 3 circular defects were made 
on the calvarium of each rabbit. Care is taken to preserve the dura. Defects were 
randomly assigned to receive 1 of the 3 test scaffolds (Figure 3). Prior closure, a 
non-resorbable membrane was positioned over the defects to prevent soft tissue 
ingrowth. This was followed by repositioning of the periosteum to cover the 
scaffolds followed by closure of the skin with sutures. The rabbits were then 
given carpofen (1-2 mg/ kg) and cephalexin ( 15-20 mg/ kg) subcutaneously for 3 
and 5 days respectively. 
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Eleven rabbits were euthanized at 2, 4, 8, 12 and 24 weeks respectively. 
All samples were processed and analyzed accordingly. The tissues surrounding the 
selected implanted scaffolds were carefully removed and stored in I O  % neutral 
buffered formalin (NBF) for histology (n = 3). The remaining samples were 
wrapped in PBS-soaked gauze and frozen at -20 °C and subsequently subjected 
for micro-CT (n = 4; non-destructive) ,  push out (n = 4), compressive strength 
testing (n = 4) analyses. The rabbits were closely monitored everyday for the 
first week for presence of swelling, pain and infection. They were then observed 
weekly for severe weight loss (20-25 % ) and any other complications. 
Mechanical strength testing 
Compressive test 
Two kinds of mechanical testing ( compressive test and push out test) 
were performed using the Instron 5500 micro tester (lnstron, Canton, MA) with 
a 1 kN load cell. Each specimen was placed between 2 flat plates for compression 
testing. The scaffolds were compressed at a speed of 1 mm/ min up to 80% of 
scaffold original thickness at room temperature. The mechanical results of load 
and extension were used to calculate the cr, Compressive Stress (MPa) = [Load (N) 
/ Area (m2)] x ( 1 x 10 6); E, Strain = Extension (mm) / Original Length (mm); and 
E, Elastic Modulus (MPa) = Compressive Stress (MPa) / Strain. A stress-strain 
curve was then plotted using the experimental data (load versus deformation) and 
the compressive modulus and strength was recorded for each specimen, with the 
stiffness being measured as the slope of the linear portion of the curve. 
Push out test 
Utilizing a similar Instron 5500 micro tester, push out test was done 
using the same configuration except that a support jig with a hole of 7.2 mm 
was used (Figure 2). Interfacial shear strength between old bone and the newly 
regenerated bone-scaffold composite was calculated by dividing peak force with 
cross sectional area of specimen. 
C,7.2 
12.5 
Figure 2: Schematic dmwing <�f specimen wule1�1{oi11g p11.1h ollf test 
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Micro-CT analysis 
Native and NaOH treated scaffolds were being isotropically scanned at 
1 4  µm resolution with an SMX-I O0CT micro-CT scanner (Shimadzu, Japan) 
using a cone CT scanning technique. To ensure a consistent CT image resolution 
among all the datasets, the scanner turntable location was fixed at a specific SOD 
(48.03 mm) and SID (36 1.30 mm) respectively. X-ray parameters were set at 33 
kV and 156 µA and the CT images were processed at a scaling coefficient of 100 
and averaged 3 times. Region of interest (6 mm diameter) was drawn at the site 
of implantation. Resultant micro-CT datasets for each bone cube were evaluated 
for microarchitectural parameters using VG Studio Max software (Heidelberg, 
Germany). Overall bone formation and scaffold volume loss were obtained and 
analyzed. 
Histological Analysis 
The specimens were removed and stored in Neutral Buffered Formalin 
(NBF) 4% and were dehydrated in ascending series of alcohol rinses and embedded 
using a process that produced ground sections with the glycol metacrylate resin. 
Once polymerized, the block is trimmed to remove excess plastic with an industrial 
vertical band saw and cut along its long axis with a diamond band saw (EXAKT 
standard saw). Ground polished sections of I O  µm thickness were made using the 
EXAKT micro grinder system (EXAKT Technologies, Inc., Oklahoma City, OK) 
and were subsequently stained with Hematoxylin & Eosin (H & E) and Goldner's 
trichrome to identify new bone formation. Three defects per group were used at 
each time point per analysis. 
Statistical Analysis 
The mechanical testing (compressive strength and push out test), resultant 
scaffold volume loss and new bone formation values were presented as mean 
values ± the standard deviation (SD) of the mean. Data analyses and comparisons 
were performed using Student's paired t-test (Microsoft Excel). P-values of < 
0.05 were considered as statistical significance. 
RESULTS 
All the rabbits used in the study remained healthy throughout the 
experiment and the healing was uneventful. All the scaffolds that were implanted 
within the assigned defects remained in-situ with no signs of migration and 
rejection. There were also no reports of any adverse complications. 
Gross morphological examination 
All scaffolds demonstrated a smooth surface appearance and excellent 
integration with the surrounding native host bone (Figure 3). In addition, all 
defect sites displayed complete closure without any signs of gaps of non-union. 
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Majority of the scaffolds at 12 and 24 weeks displayed harmonious blending of 
the regenerated bone within the defect site with regards to color and texture. On 
palpation, the repaired sites were firm and stiff comparable to the adjacent host 
native bone. Numerous tiny blood vessels formation was observed within the 
newly regenerated PCL-TCP scaffolds in all 3 groups. 
Figure 3: Gro.1.1 photographs of the rabbit call'(tria (A) 12 weeks and ( B) 24 weeks following 
implantation of the scaffold.1 in the defects. The scaffolds were fully integrated into the 
.1·111-,-01111ding hO\t bone de11oid of any fibrous encapsulation orforeign body reaction. 
Blood ves.1el.1 formatio11 ll'ere observed within all the reconstructed scaffolds 
Mechanical testing 
Compressive strength test 
In this study, compressive strength was defined as the strength taken 
at 50% strain. Elastic modulus was taken at 79% strain as compared to at I %  
strain normally in order to account for the uneven and irregular surface of the 
specimens. 
The compressive strength of the various treatment groups of PCL-TCP 
scaffolds over the duration of implantation is shown in Figure 4. Generally, the 
NaOH treated groups showed superior compressive strength values primarily 
during the early phases of healing (2 weeks: Group A ( 4 ± 1.47 MPa), B ( 4. 15 ± 
1.43 MPa), C (5. 15 ± 1 .74 MPa); 4 weeks: Group A (5.92 ± 3.87 MPa), B (6.61 ± 
3.6 MPa), C (9.86 ± 5. 17 MPa); 8 weeks: Group A (7.92 ± 3.68 MPa), B ( I  1.0 1 
± 5.5 1 MPa), C ( 15. 1 1  ± 9 . 19 MPa)). A decrease in compressive strength was 
reported in the later phases of healing throughout the 3 treatment groups. This 
reduction occurred earlier in the NaOH treated groups at 12 weeks as compared 
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Push out test 
Figure 5 shows the push out test results of the various treatment groups of 
PCL-TCP scaffolds over the duration of implantation. Overall, increasing surface 
roughness of the scaffolds displayed a modest impact on the resultant push out 
test values of the treated scaffolds. Similar to the compressive strength results, a 
decrease in push out test values of the scaffolds was reported in the later phases 
of healing ( 12 - 24 weeks) in the NaOH treated groups, where only scaffolds 
from Group B showed a rebound in values. Scaffolds from the untreated group 
in general did not report any changes in the push out test values after 2 weeks 
following implantation. 
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Micro-CT analysis 
Micro-CT was utilized to determine the cumulative loss of scaffold 
volume (Figure 6 and 7) and the volume of new bone formation (Figure 8) 
detected 2, 4, 8, 12 and 24 weeks after implantation. Results revealed that the gross 
honeycomb-like pattern of the interconnected pore network within the PCL-TCP 
scaffolds was generally maintained throughout the 24 weeks. However, signs of 
cracks and distortions were detected on the scaffold rods of the NaOH treated 
groups as early at 4 weeks. Figure 7 demonstrates the resultant scaffold volume 
detected at various time points for the different PCL-TCP scaffold groups. PCL­
TCP scaffolds from all 3 groups measured a mean volume of 18. 1 ± I mm3 at the 
start of the experiment. In addition, comparable resultant scaffold volume in all 
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Resultant PCL-TCP scaffold volume under different NaOH treatment e.\posures over 
time. Data are shown as mean ± SD 
Surface modified scaffolds demonstrated a positive effect on the extent 
of degradation as they reported 50 % scaffold volume losses earlier than the 
unmodified group. Scaffolds from Group C showed 50% degradation earliest 
around 4 weeks (8.6 ± 0.94 mm3), Group B around 8 weeks (8.32 ± 1.79 mm3) 
whilst Group A required approximately 12 weeks (9.6 ± 2.41 mm3) before 
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After the initial 2 weeks of implantation of the PCL-TCP scaffolds, 
micro-CT analysis showed superior new bone formation in the NaOH treated 
groups as compared to the untreated group throughout the 24 weeks. Significant 
increase in bone formation was detected after 8 and 12 weeks (p < 0.05). Across 
the 3 treatment groups, the volume of new bone formation reported the highest 
values between 8 - 12 weeks following implantation of the scaffolds (Group A 
( 12 weeks): 18.29 ± 3. 14 mm3; Group B (8 weeks): 23. 1 1 ± 3. 1 1  mm1 ; Group C 
( 12 weeks): 2 1.5 I ± 2.8 mm3). Interestingly, the amount of new bone formation 
detected at 24 weeks decreased accordingly whilst retaining a similar trend across 
the 3 treatment groups. 
Figure 8: 
2 v.eeks 4 v.eeks 8 v.eeks 
Time (waeka) 
• Groop A Cl Group B • Group C 
12 ...,eks 24 weeks 
New bone formation within PCL-TCP scaffolds under different NaOH treatment 
expo�ures over time. Data are shown as mean ± SD. ( ) Indicates statistical 
signijicallf mean bone volume detected (p < 0.05) between ullfreated and NaOH 
treated scaffolds 
Histological analysis (Qualitative evaluation) 
There was no evident distinction between the appearance and presentation 
of the scaffold across all the 3 treatment groups. There were no signs of generalized 
inflammatory activity or the formation of fibrous encapsulation in any of the 
histological specimens. Due to the process of histological preparations, the PCL­
TCP scaffold was dissolved and in place represented as empty lacunae. 
2 weeks: 
All defects, regardless of the scaffold treatment groups, demonstrated 
presence of a blood clot within the granulation tissue and fibrin matrix. Distinct 
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arrangements of the scaffold rods were seen evenly distributed throughout the 
specimens. Interestingly, presence of obvious accumulation of inflammatory cells 
was detected in close proximity to the non-resorbable membrane; however, no 
signs of any inflammatory reaction were reported related to the scaffold material 








Representative histological images ( H & E �tain) of a PCL-TCP scaffold following 
implantation in the calvaria of a rabbit after 2 weeks. Note the generalized 
appearance of a blood clot within a fibrin network (A) ( /OX magnification) and 
the intense presence of infla111111ato1)' cells detected beneath the non-resorbab/e 
membrane (B) (40X magnification) 
4 to 8 weeks: 
Considerable amount of bone formation were noted across all 3 treatment 
groups. Bone was seen infiltrating within the pores of the scaffold rods and along 
the surfaces of the scaffolds. Signs of bridging extending from the periphery of 
the host bone into the defect were noted. The deposition of bone presented as a 
slightly mature mineralized central portion and an outer region of newly formed 
and immature osteoid. In contrast to the 2 weeks' findings, a decrease in the 
amount of inflammatory cells was observed beneath the non-resorbable membrane; 
conversely, multinucleated osteoclast-like giant cells were increasingly detected 
on the surfaces of the scaffold rods and are closely associated with adipose cells. 
In addition, numerous vascular vessels were shown interspersed as well. Presence 
of an intense inflammatory reaction or a fibrous encapsulation related to the 
scaffolds was not detected. (Figure 10) 
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Figure JO: Go/dner's trichrome staining (mineralized tissue = green; osteoid :::: red) reveals 11e1Vly 
formed woven bone trabeculae after 4 weeh along IVith the presence of numerous blood 
vessels distributed across the defect site (A) ( ]OX magnification). Multi-nucleated giant 
cells are detected on the surfaces of the scaffold rods and are closely associated IVith 
adipose cells as early as 4 weeks after i111plantatio11 (BJ (40X 111ag11ificatio11). 
12 to 24 weeks: 
The later phases of healing presented with increased fill of trabecular bone 
and adipose cell-rich bone marrow tissue surrounding the occasional scaffold rods 
throughout the entire defect space. Majority of the defect filled sites demonstrated 
a compact bone arrangement immediately beneath the non-resorbable membrane. 
The volume fraction of the adipose cell-rich bone marrow tissue was noted to have 
increased mainly at 24 weeks. Signs of an overt inflammatory reaction were absent in 
all specimens related to the scaffolds. In areas where multinucleated osteoclast-like 
giant cells were identified, they were often located on the surface of the scaffold rods 
that were intimately associated with adipose cell-rich bone marrow tissue. (Figure 1 1) 
Figure 11: 
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Goldner's trichrome staining (mineralized tissue = green; orteoid = red) reveals an 
increase in 1•0/umefraction of the adipose cell-rich bone marro\\l tissue \\las noted pri111arily 
after 24 weeks follolVing implantation ( A) ( /OX magnification) and ( B) ( 5X magnification). 
Presence of blood vessels can be seen widely distributed across the defect specimens. 
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DISCUSSION 
Preliminary results from our earlier studies demonstrated that alkaline 
modification of PCL-TCP scaffolds improved surface properties and early 
bone formation. In this current study, a comprehensive analysis was performed 
to investigate the degradation profile, mechanical properties and bone healing 
patterns of similarly modified PCL-TCP scaffolds over a period of 24 weeks in a 
rabbit calvaria defect model. 
A rabbit calvaria defect model has been well established in the assessment 
of biomaterials targeted for bone regeneration applications. 1 • 23• 24 Unlike majority 
of these studies, in which the critical-sized defects were used, the present study 
did not intend to utilize critical-sized defects to investigate the effects of surface 
modified PCL-TCP scaffolds. The objective of the study aimed to compare 
scaffolds with varying exposures intervals to NaOH treatment and to determine 
the effects on the degradation profile, biomechanical properties as well as the 
bone healing patterns. Alkaline treatment of PCL based scaffolds has been shown 
in vitro and in vivo to accelerate the degradation process through surface erosion 
and an increased exposed surface area for further hydrolytic chain scissions. 2 1 . 
25 In addition, no reports of adverse host tissue reactions or cytotoxicity were 
favorably reported when NaOH pre-treated PCL or PCL-TCP scaffolds were 
implanted in animal models. 22• 25 Our recent study demonstrated that although 
NaOH treated PCL-TCP scaffolds displayed altered surface characteristics, 
there was no significant changes to the physical and structural characteristics. 
The overall pore dimensions and the ideal honeycomb interconnected remained 
intact. 
Upon implantation of the treated and untreated PCL-TCP scaffolds, 
surface degradation and erosion commenced. This involved hydrolytic cleavage 
of the polymer backbone primarily at the surface and less into the bulk of the 
polymer without affecting the overall molecular weight, physical or chemical 
attributes. During the early phases of healing following implantation, the rate 
of scaffold volume loss was achieved faster in the NaOH treated groups than 
the untreated group. This was due to the increase in exposed surface areas that 
resulted initially from the formation of numerous microcavities and 'channel­
like' indentations on the scaffold rods after pretreatment with NaOH. Unlike 
the untreated PCL-TCP scaffolds, the treated ones displayed cleaved chains and 
oligomers that encouraged rapid clearance. However, the scaffold volume loss 
remained comparable during the later phases of healing, suggesting that once the 
superficial layer of the polymer had been removed after 12 weeks, the scaffold 
features were similar to that of the untreated and native PCL-TCP scaffolds. 
Our assessment of bone healing patterns included micro-CT and 
histological analyses. Micro-CT was employed to provide an accurate means to 
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quantify bone and its spatial growth and three-dimensional distribution. Histology 
images were used to determine the qualitative aspects of bone formation, vascular, 
cellular and inflammatory activities. As expected from micro-CT data, scaffolds 
with increased surface roughness demonstrated superior bone formation as 
compared to the untreated group throughout the experiment. Histological analyses 
over the progressive time points revealed increasing amounts of bone and adipose 
tissue infiltrating the pores in all scaffolds. In addition, numerous vascular vessels 
were seen interspersed within the regenerated defect sites. The presence of 
intense inflammatory cells or fibrous encapsulation was not detected. However, 
multinucleated osteoclast-like giant cells were identified in close approximation 
to the surface of the scaffold rods that were intimately associated with adipose 
cell-rich bone marrow tissue. It is important to note that these multinucleated 
osteoclast-like giant cells are primarily located on the surfaces of the PCL-TCP 
scaffold rods and do not demonstrate presence of any resorption lacunae on the 
newly formed bone as shown similar by other studies. 26• 27· 28 This is in accordance 
to the phenomenon that was described by Pogoda and co-workers as 'functional 
coupling in the bone metabolic unit (BMU)' .  29 It demonstrated the characteristics 
of the absence of osteoclast-associated resorption lacunae in the BMU and no 
quantitative reduction of bone volume. The multinucleated giant cells observed in 
the present study behaved primarily as macrophages, where the removal of graft 
particles would enable deposition of new bone to occur. Interestingly, a modest 
decrease in the overall bone volume was detected from micro-CT from 12 weeks 
to 24 weeks ( 19. 15 % - 24.56 %) across all the 3 treatment groups. Conversely, 
results from the histological analyses demonstrated an increased volume fraction 
presence of adipose cell-rich bone marrow tissue surrounding the bony trabeculae. 
At this stage of healing, considerable remodeling of the bone could have occurred 
and adopted a cancellous nature. 
The compressive test was conducted to investigate the mechanical 
integrity of the reconstructed scaffold-new bone composite. The push-out test 
was designed to examine the integration strength of the scaffold to the host bone 
of the calavria walls surrounding the defect. This was achieved by measuring the 
amount of strength required to fracture the reconstructed scaffold from the defect 
site. Results from the mechanical testing demonstrated a substantial variance 
in values. This was largely due to the differences in structural morphology, 
cross-sectional thickness and trabecular density of the rabbits' calvaria, despite 
controlling the age, gender of the rabbits and maintaining the size and positions 
of the defect sites. In general, mechanical testing results revealed improved values 
of the NaOH treated scaffolds as compared to the untreated scaffolds primarily 
during the early phases of healing following implantation of the scaffolds. This 
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proved favorable during the initial consolidation process of the implanted scaffolds 
where superior structural stability of the system was achieved as early as 8 weeks. 
Compressive strength analyses reported a decrease in readings at the later stages 
of healing, in which on average closely matched to that of cancellous bone. 30• 3 1  
This findings corroborated with the earlier discussion from the histological data, 
in which the properties of the remodeled bone was suggested to have assumed a 
more cancellous type characteristic after initial bone healing had taken place. Due 
to the absence of load bearing forces in the calvaria region, our group proposed 
that during the later stages of healing, remodeling of bone occurred. This might 
result in a loss of bone mass and eventually adopt a less compact nature. The 
importance of mechanical loading for the maintenance and increase of bone mass 
was described early as the classic Wolff 's Law 32 and is universally accepted 
today. 33 In addition, we believe that the clearance of the PCL-TCP polymer by 
the macrophages could encourage adipose clusters to be deposited. This was 
clearly reported in several of the studies that investigated the use of PCL-TCP 
scaffolds although it has yet to be proven. 1 • 18• 25 Overall, the mechanical properties 
of both treated and untreated PCL-CTP scaffolds were shown to be favorable 
throughout the experiment, more importantly during the early phases of healing. 
This is essential especially in dentoalveolar applications where the oral cavity is 
constantly under the influence of moderate load bearing forces. 
CONCLUSIONS 
Selective surface modification of PCL-TCP scaffolds were implanted in 
calvaria defects of rabbits and evaluated for scaffold degradation, mechanical 
properties and patterns of bone formation. Throughout the experiment, scaffolds 
with increased surface roughness displayed encouraging results when new bone 
formation and mechanical properties were analyzed as compared to untreated and 
native ones. Based on the promising results from our rabbit study, we are currently 
in the process of investigating the potential of modified PCL-TCP scaffolds in a 
large animal model involving more challenging dentoalveolar defects. Here, a 
clinically relevant defect model will allow load-bearing forces to be taken into 
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Loss of human tissues or organs is a devastating problem that can affect 
individuals of all ages. Bone, a complex living tissue that provides internal support 
for all higher vertebrates, is currently heralded as the most commonly replaced 
organ of the body. In fact, with over 1.3 million bone repair procedures performed 
per year in the United States alone, 1 the ability to come up with an innovative 
and effective treatment to satisfy the major clinical need has indeed been a great 
challenge for many researchers. 
In implant dentistry, we are often faced with clinical situations where 
major defects or deformities are the result of trauma or diseases. The outcome is a 
compromised and deficient alveolar ridge, which is often extended, non-contained 
and frequently requiring extensive GBR procedures. In the dentoalveolar 
skeleton, an inadequate bone volume often creates problems in the prosthetic and 
aesthetic reconstruction of partially and completely edentulous situations. In an 
era where implant borne tooth restorations have become the standard of care for 
the replacement of missing teeth, 2· 3 the quantity and quality of the available bony 
ridge is critical in determining whether ridge augmentation is required prior to 
dental implant placement. 
For a long time, autogenous bone, allogenic bone grafts and xenografts 
have been used for treatment in bone defects. However, these techniques have 
some drawbacks. Harvesting of autogenous bone grafts induces additional trauma 
and morbidity, increases operation times, presents risk of partial resorption and 
often the grafts that are harvested are limited in supply. Allogenic bone grafts 
and xenografts present risks of possible contamination and problems of religious 
implications. 4• 5 These limitations and restrictions have triggered further research 
aiming to develop novel bone substitutes for dentoalveolar applications. 
Our research team has developed synthetic block scaffolds that possess 
excellent bioactive, bioresorbable and biodegradable properties, by combining 
PCL with 20% TCP for bone regeneration procedures. As compared to the first 
generation of pure PCL scaffolds, PCL-TCP scaffolds were similarly fabricated 
using a highly reproducible and predictable fused deposition modeling (FDM) 
technique. 6 These bioresorbable PCL-TCP scaffolds possess a completely 
interconnected architecture with a regular porous morphology that is favorable 
for cellular conduction <, as well as protein loading and release. 7 In addition, 
these scaffolds demonstrated a bioactive nature by nucleating the formation of 
hydroxyapatite on its surface upon immersion in simulated body fluids. 8 To date 
we have investigated the use of PCL-TCP scaffolds in the regeneration of bone 
targeted for dentoalveolar applications. 
1 46 
General Discussion 
This series of 5 articles investigated and described the development of 
the PCL-TCP scaffolds from in vitro experiments to in vivo small animal models. 
The first article (Chapter 2) studied the comparison of calcium phosphate based 
bone substitutes and autogenous bone grafts in mandibular defects of minipigs. 
The study clearly demonstrated that rate of bone formation is dependent on 
the degradation rates of bone grafting material utilized. In addition, it showed 
comparable results of TCP and autogenous bone grafts in the formation of new 
bone into the defects during the early phases of healing. This clearly led to 
our team's decision to incorporate TCP to pure PCL as scaffolds used in our 
subsequent studies. The second article (Chapter 3) examined the degradation 
profile and properties of TCP-incorporated PCL scaffolds in vitro in culture 
growth medium and in vivo in an aggressive environment of the abdomen of 
rats. Degradation rates of PCL-TCP scaffolds were accelerated. However, this 
was still not optimal for dentoalveolar reconstruction applications and further 
research targeting to accelerate the degradation rates was carried out (Chapter 
4 ). Once this was established, the following article (Chapter 5) described the 
surface and structural characterization of the newly customized NaOH modified 
PCL-TCP scaffolds performed. When analyzing the early phases of bone healing, 
clearly the NaOH modified scaffolds reported superior mechanical properties 
and new bone formation. The final article (Chapter 6) concluded by investigating 
the degradation profile, biomechanical properties and bone healing patterns of 
NaOH modified scaffolds in rabbit calvaria defects over a period of 6 months. 
Promising results reported in this study encourages the potential use of the PCL­
TCP scaffolds for the reconstruction of dentoalveolar defects. On-going studies 
are currently being performed to investigate the use of these NaOH modified 
scaffolds in a clinically relevant mandibular defect pig model. 
In vivo evaluation of calcium phosphat e based bone substitutes and 
autogenous bone grafts (Chapt er 2) 
The aim of this present study was to compare bone formation and the 
degradation of autogenous bone and calcium phosphate based grafting materials 
within standardized intraosseous defects in the mandibles of a minipig model. The 
mini pig was chosen for the present study because of its close similarity to humans 
in terms of bone healing and bone structure. 9 The defects created in the study 
were not intended to be of critical-size defects. Firstly, the bone grafting materials 
utilized in this study has previously been proven, as proof of concept, the ability 
to regenerate new bone formation. Secondly, the current experiment is clearly a 
comparative study between autogenous bone and calcium phosphate based bone 
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substitutes. Thirdly, the use of non critical-size defects would logically reduce the 
total number of defects required per side and in turn decrease the overall number 
of animals indicated for the entire experiment. 
Results from the study demonstrated comparable bone formation of 
autogenous bone and TCP only bone substitutes as compared to HA incorporated 
bone substitutes during the early phases of healing. The superior bone healing 
outcomes obtained from autogenous bone and TCP only bone substitutes were 
due to the faster degradation rates reported. This allowed new bone formation 
to occur within the defects without hindrance from the slower substituted HA 
incorporated bone grafts as shown. 
Our team based on the importance of degradation profile when developing 
novel of bone substitutes for targeted dentoalveolar applications. TCP is a 
ceramic that has been shown to possess bioactive properties. When soaked in 
simulated body fluids (SBF), a calcium-rich layer was found nucleated on the 
PCL-TCP scaffold's surface that finally resulted in hydroxyapatite precipitation 
after 2 weeks of immersion. 8 The incorporation of TCP to our first generation 
of pure PCL scaffolds aimed to fabricate a hybrid or composite material. We 
hypothesized that the addition of TCP can help accelerate the degradation of the 
PCL polymer and also encourage higher interfacial strength between the scaffold 
and new bone. 
Degradation profil e of bioresorbabl e PCL-TCP scaffolds (Chapt er 3) 
PCL-based polymers are hydrophobic in nature and have shown to 
degrade completely at a slow rate of around 3-4 years. to. t i  This is due to the high 
molecular weight and the slow diffusion rate of water internally within the scaffold 
construct. 12 In another in vivo study, PCL scaffolds implanted in rats remained 
intact even after 2 years with the second stage of degradation commencing only 
around 30 months following implantation. 13 Due to its hydrophilic nature, the 
addition of TCP to the PCL scaffolds proved valuable as the overall degradation 
rate was accelerated both in vitro and in vivo. Interestingly, throughout the phases 
of degradation, the PCL-TCP scaffolds tested in this study maintained their 
pore interconnectivity as they became more porous. This proved advantageous, 
as it would encourage the development of a vascular network to allow for the 
infiltration of nutrients, cells and growth factors within the system. 14  
In general, synthetic biodegradable scaffolds often do not posses favorable 
mechanical properties. The PCL-TCP scaffolds used in our study recorded an 
average compressive strength of 6.38 MPa at baseline, which closely matches 
to that of human cancellous bone, 15 indicating that the PCL-TCP scaffolds have 
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reasonable mechanical strength to withstand load-bearing masticatory forces in 
the oral environment during the initial phases of healing. Although the results 
reported a significant degradation of the PCL-TCP scaffolds in vivo at 6 months, 
the second stage of degradation had not commenced. Selective modification of 
the PCL-TCP scaffolds to further accelerate the degradation process is intended. 
This is in line with our strategy for dentoalveolar reconstruction applications, 
whereby the PCL-TCP scaffolds should gradually degrade and lose its physical 
properties until approximately 5-6 months when the newly regenerated bone can 
support itself. 
Customizing the degradation and load-bearing profile of 3D PCL-TCP 
scaffolds (Chapter 4) 
This research was intended to expand the preliminary work on PCL­
TCP scaffolds as synthetic grafts for guided bone regeneration. In this study, our 
strategy was primarily to increase the degradation rate of the PCL-TCP scaffolds 
prior to dental implant insertion, whilst preserving its mechanical properties. 
The present study was aimed at monitoring the in vitro degradation of 
the scaffolds via NaOH and lipase treatments. A greater degree of degradation 
and reduction in the physical properties of the scaffolds was observed in the 
lipase-treated as compared to NaOH-treated scaffolds. The resultant increase in 
hydrophilicity was reported due to the exposure of the ends of the carboxylic 
chains during hydrolysis of the PCL scaffolds. 16 In this study, a low concentration 
(3M NaOH) was utilized in our study in order to achieve a more controlled and 
predictable degradation of the scaffolds. Our preliminary findings using higher 
concentrations of NaOH produced an inconsistent and a too rapid degradation 
(unpublished data). The use of 0. 1 % lipase in our study demonstrated less than 
consistent degradation profile and resulted in an unfavorable surface topography. 
Signs of cracks, distortions and distinct thinning of the rods were observed 
rendering the PCL-TCP scaffolds mechanically and physically compromised. 
The modified surface roughness that resulted from the NaOH-treated 
scaffolds was manifested as indentations of microporous dimensions. We proposed 
that the increased surface roughness resulted from the surface erosion during 
NaOH treatment may also contribute to cell attachment and proliferation. This 
offers a promising surface topography for new bone formation to occur. This was 
in contrast to the scaffolds after lipase treatment, where a less than consistent and 
an unfavorable surface topography. Overall, the honeycomb-like architecture was 
well preserved throughout the experiment only for the NaOH-treated scaffolds. 
Compressive strength testing measured in the NaOH-treated group demonstrated 
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values comparable to that of human cancellous bone. In general, our results and 
development of the modified NaOH-treated scaffolds is promising in tailoring 
the physical properties and degradation rate to suit dentoalveolar applications. 
Subsequent studies to further evaluate our preliminary findings are required to be 
conducted utilizing bone defects in a small animal model. 
Effects of surfac e modification of PCL-TCP scaffolds (Chapter 5) 
This study was an extension of earlier research works in which our team 
evaluated the degradation profiles of PCL-TCP scaffolds. 1 7• 1 8  The aims of the 
study planned to characterize the surface and structural properties of PCL-TCP 
scaffolds when treated with NaOH at various exposure intervals. In addition, we 
intended to investigate the in vivo effects of surface modification of the scaffolds 
influencing early bone formation in a rabbit calvaria model. 
Overall, we observed greater degree of surface and physical changes 
in the NaOH-treated scaffolds as compared to the untreated group. A greater 
number and size of micro pits were detected in the NaOH-treated scaffolds as 
compared to the untreated ones. Interestingly, these treated scaffolds displayed an 
appearance of enhanced 'channel-like' indentations, which significantly increases 
the surface area to volume ratio of the scaffolds. This is optimal for matrix 
deposition and cellular attachment during the early phases of healing. Ultimately, 
a greater bone-polymer interaction would encourage a greater interfacial 
mechanical interlock during healing. This is clearly advantageous especially 
when bone tissue remodeling is taking place whilst being under constant load 
bearing conditions in the oral cavity. Another positive observation showed that 
the scaffold architecture and pore morphology, which was measured as mean rod 
thickness and mean pore separation respectively, remained constant throughout 
the in vitro experiment, hence preserving the physical and mechanical properties 
of the PCL-TCP scaffolds. 
In the in vivo part of our study, we reported favorable healing and no reports 
of any complications throughout the experiment. SEM images demonstrated 
increased early ECM deposition and cell attachment on the surface of the NaOH­
treated PCL-TCP scaffolds as compared to the untreated ones. Improved new 
bone formation from microCT analyses confirmed similar trends. Our results 
strongly suggest the potential selective modification of PCL-TCP scaffolds via 
NaOH treatment to improve early bone healing. 
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Effects of d egradation profil e, biom echanical prop erti es and bone h ealing 
patt erns of surfac e modifi ed PCL-TCP scaffolds (Chapter 6) 
In this current study, a comprehensive analysis was performed to 
investigate the degradation profile, mechanical properties and bone healing 
patterns of similarly modified PCL-TCP scaffolds over a period of 24 weeks in a 
rabbit calvaria defect model. Similar to the first study that was conducted in the 
minipig model, the present study did not intend to utilize critical-sized defects to 
investigate the effects of surface modified PCL-TCP scaffolds in calvaria defects 
of rabbits. 
Our assessment of bone healing patterns included micro-CT and 
histological analyses. Micro-CT was employed to provide an accurate means to 
quantify bone and its spatial growth and three-dimensional distribution. Histology 
images were used to determine the qualitative aspects of bone formation, 
vascular, cellular and inflammatory activities. As expected from micro-CT data, 
scaffolds with increased surface roughness demonstrated superior bone formation 
as compared to the untreated group throughout the experiment. Histological 
analyses over the progressive time points revealed increasing amounts of bone, 
adipose tissue and numerous blood vessels interspersed and infiltrating the pores 
in all scaffolds. Although the presence of any intense inflammatory reaction 
were not detected, multinucleated osteoclast-like giant cells were identified 
in close approximation to the surface of the scaffold rods that were intimately 
associated with adipose cell-rich bone marrow tissue. It is important to note that 
these multinucleated osteoclast-like giant cells were predominantly observed 
on the surfaces of the PCL-TCP scaffold rods. They behaved primarily as 
macrophages and were focused on the removal of the graft material and were 
not directly involved in the resorption of bone. 1 9· 20· 2 1  An interesting finding from 
the histological analyses demonstrated an increased volume fraction presence 
of adipose cell-rich bone marrow tissue surrounding the bony trabeculae. Our 
team proposed that considerable remodeling of the bone could have occurred and 
adopted a cancellous nature. Firstly, the clearance of the PCL-TCP polymer by 
the macrophages could encourage adipose clusters to be deposited as reported in 
several of the studies that investigated the use of PCL-TCP scaffolds although it 
has yet to be proven. 1 7• 22• 23 Secondly, due to the absence of load bearing forces 
in the calvaria region, remodeling of bone occurred. This might result in a loss of 
bone mass and eventually adopt a more cancellous nature. 
Generally, the mechanical properties of both treated and untreated PCL­
CTP scaffolds were shown to be favorable throughout the experiment. As expected, 
our study reported improved mechanical testing results in the NaOH-treated 
scaffolds as compared to the untreated scaffolds primarily during the early phases 
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Chapter 7 
of healing following implantation of the scaffolds. This proved favorable during the 
initial consolidation process of the implanted scaffolds where optimal structural 
stability of the system is required to withstand forces within the oral cavity. 
In light of the promising results obtained from the rabbit study, we plan 
to further evaluate these modified PCL-TCP scaffolds targeted for dentoalveolar 
reconstruction applications. We are currently in the process of investigating the 
potential of modified PCL-TCP scaffolds in a large animal model involving more 
challenging dentoalveolar defects. Here, a clinically relevant defect model will 
allow load-bearing forces to be taken into considerations in the oral cavity. 
CONCLUSIONS 
A large number of experimental animal studies have evaluated GBR 
techniques using autogenous bone grafts, bone fillers and barrier membranes. 
However, a majority of these animal studies investigated the outcomes of such 
techniques in extraoral bone defects that are either non-representative nor 
clinically relevant. These defects are often 'freshly created' or acute, contained 
and limited in size, unlike the typical clinical situation presented in patients, 
where a chronic and large bone defect is most common. A need for a more 
demanding and a clinically representative animal model is required for future 
studies when analyzing the success and predictability of a GBR technique. Our 
team has recently completed the study evaluating the use of PCL-TCP scaffolds 
for the reconstruction of localized dentoalveolar defects in a pig model. In 
summary, a total of 12 micropigs (PWG, Genetics, Korea) were utilized for the 
study. Bilateral defects were created in the posterior mandible and were left to 
heal. Following a healing period of 2 months, the defects were planned for a 
GBR procedure and the defects were randomly selected to receive either one 
of the following GBR procedures (i) Collagen membrane + PCL-TCP scaffold 
(ii) Collagen membrane + autograft. Preliminary results from the I s, group of I 0 
micropigs are promising and have shown the potential of PCL-TCP scaffolds 
for use in dentoalveolar applications. Micro-CT analysis has demonstrated that 
GBR utilizing PCL-TCP scaffolds yielded a mean ratio of approximately 0.6 
when bone-to-tissue volume fraction (BV ffV) of the PCL-TCP scaffold groups 
were compared to that of autogenous block grafts within the same animal. Data 
from histology and histomorphometry analyses will be determined at a later 
stage. The remaining 2 micropigs will be assigned for dental implant insertion 
following six months of healing after scaffold implantation at a later date (on­
going). Evaluation of the dental implants within the newly regenerated bone will 
be performed by measuring the resonance frequency analysis (RFA), microCT, 
histology and histomorphometry analyses. 
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General Discussion 
It should be noted that the predicate device, pure PCL scaffolds, are Food 
and Drug Administration (FDA) approved for craniofacial indications but are slow 
degrading and hence not optimal for implant dentistry applications. Already, two 
separate pilot clinical trials have been recently conducted. The first one evaluated 
pure PCL scaffolds as burr hole plugs for cranioplasty after trephination for patients 
diagnosed with chronic subdural hematoma. The scaffolds were anchored firmly 
in the osseous host environment with no fluid collection detectable. Follow-up 
radiographic scans after I 2 months revealed that the implants were well integrated 
in the surrounding calvarial bone with new bone filling the porous space. 24 The 
second trial tested also pure PCL scaffolds in a sheet form for the reconstruction 
of the orbit in patients diagnosed with orbital fractures. Follow-up scans after 12 
months, demonstrated that there was no prolapse of the orbital contents and the 
scaffold of the orbital floor was in a satisfactory position. It was found to integrate 
with the surrounding tissues, thereby minimizing the risk of subsequent implant 
migration and extrusion. 
Clearly, preliminary results from the micropig model reported a shortfall 
of the PCL-TCP scaffolds when compared to the 'Gold Standard' autogenous 
bone transplants. Additional preclinical studies are being outlined to further 
improve the bone formation capacity of pure PCL-TCP scaffolds beyond their 60% 
efficacy when compared to autogenous block grafts. These include the fabrication 
of 3rd generation PCL based scaffolds where our team plans to incorporate 
biological mediators and growth factors. In addition, we are in collaboration with 
a tissue engineering lab to utilize the use of bioreactor technology to enhance 
the proliferation and osteogenic differentiation of porcine-derived bone marrow 
mesenchymal stem cells (MSC) mediated scaffolds within the PCL-TCP scaffold 
constructs. Bioreactors have been shown to improve flow perfusion of cellular 
scaffolds; promoting and maintaining homogenous cell growth within large 
grafts for optimal bone formation to occur. Our team hopes that in the process of 
developing a successful preclinical model, we can proceed to conduct a pilot study 
to prove that the construct model can be used safely and predictably, similarly to 
an autogenous bone graft substitute for the reconstruction of dentoalveolar defects 
in the partially edentulous maxilla. The study will evaluate the long-term stability 
and integration of the PCL-TCP scaffold to the augmented site prospectively. 
In addition, the clinical survival and success of the dental implants in the newly 
regenerated bone will be assessed. If proven successful, the need for autogenous 
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The introduction describes the predictability of implant dentistry in the 
treatment of patients with partial or complete edentulism. In addition, it provides 
an overview of the limitations faced when presented with dentoalveolar ridge 
deficiencies and the success of Guided Bone Regeneration (GBR) in restoring such 
defects. Issues on the use of autogenous, allogenic and xenogenic bone grafts have 
generated immense interest to develop novel bone substitutes for dentoalveolar 
applications. A list of favorable properties is listed when choosing a scaffold. Our 
teams' choice of selecting PCL scaffolds from a plethora of synthetic polymers 
was based on the superior mechanical properties and biocompatibility reported 
from earlier studies. Our objectives of the study were designed to investigate 
the potential use of PCL-TCP scaffolds and further customize its applications 
ultimately for dentoalveolar applications. 
CHAPTER 2 
The objective of the study planned to investigate 4 different groups of 
bone grafting materials in standardized bone defects in the angle of mandibles 
of 16 minipigs. The defects were randomized to the following assigned bone 
grafting materials: 
I .  Autogenous bone chips 
2. Hydroxyapatite (HA) 
3. Hydroxyapatite/ Tri-calcium phosphate (HA/ TCP; 60%: 40%) 
4. Tri-calcium phosphate (TCP) 
Histology and histomorphometry analyses were performed after 2, 4, 8 
and 24 weeks of healing. After 2 weeks of healing, autogenous bone grafts reported 
greatest bone formation as compared to the synthetic bone substitutes. After 4 
and 8 weeks, autogenous bone and TCP demonstrated superior bone formation 
than the HA-based bone grafting materials. However, at the end of 24 weeks, 
all test groups showed similar bone formation and favorable intimate contact of 
bone grafting materials and the host bone. The bone healing patterns in this study 
suggested that the rate of bone formation is dependent on the degradation rates of 
the bone grafting materials utilized. Autogenous bone and TCP has been shown 
to degrade at a faster rate allowing the formation of new bone into the defects 
during the earlier phases of healing. In contrast, the limited resorption rates of 





The study was conducted to investigate the degradation profile and 
physical properties of PCL-TCP scaffolds when immersed in standard culture 
medium under physiological conditions for 24 weeks and the in vivo degradation 
profile for PCL-TCP scaffolds when implanted in the abdomen of rats for 24 
weeks. Changes in molecular weight, porosity, mechanical properties and surface 
morphologies were analyzed. 
In vitro and in vivo degradation of PCL-TCP scaffolds behaved differently 
over the course of 24 weeks. The extent of degradation of PCL-TCP scaffolds in 
vivo was greater than in vitro immersed in culture growth medium. When implanted 
in the abdomen of rats, the scaffolds generally degraded more rapidly. At 24 weeks, 
the increase of average porosity of the scaffolds in vivo was significantly greater 
than in vitro. The PCL-TCP scaffolds utilized in this study maintained their pore 
interconnectivity as they became more porous, which was ideal as this encourages 
a more extensive vascularization throughout the scaffold. GPC analyses revealed 
a similar trend whereby a significant decrease in the M and M values was 
n w 
demonstrated in vivo as compared to that in vitro after 24 weeks. 
CHAPTER 4 
Surface modifications of the PCL-TCP scaffolds via chemical and 
enzymatic means were performed whilst preserving favorable surface and physical 
properties. The present study was aimed at monitoring the in vitro degradation 
of the scaffolds with either 3M sodium hydroxide (NaOH) or 0.1 % lipase 
solution for a total of 108 hours. A greater degree of degradation and reduction 
in the physical properties of the scaffolds was observed in the lipase-treated as 
compared to NaOH-treated scaffolds. Data from the study demonstrated increase 
in weight loss and average porosity of the scaffolds in the lipase-treated group 
measured 90.6% and 22.9% respectively as compared to 52.8% and 1 1 .8% in 
the NaOH-treated group at the end of the experiment. The mechanical testing 
results revealed a similar trend, with a complete loss of compressive strength and 
modulus measured as early as 60 hours in the lipase-treated group. 
Overall, our study confirmed that selective modification using NaOH 
produced PCL-TCP scaffolds with increased surface roughness manifested 
as indentations of microporous dimensions. This offers a promising surface 
topography for bone formation to occur as compared to the lipase-treated group. 
In conclusion, pretreatment with NaOH demonstrates a simple approach for 
tailoring the physical properties and degradation rate of PCL-TCP scaffolds for 




This study aimed to modify the PCL-TCP scaffolds by NaOH pretreatment 
with the intention of altering the surface characteristics of the scaffold rods. In 
the in vitro section, the study focused on the alterations in surface characteristics, 
hydrophilicity, pore morphology and structural architecture of PCL-TCP scaffolds 
when treated with NaOH under varying time intervals (0, 48 and 96 hours). 
Results from the in vivo section analyzed early matrix and cellular deposition on 
the scaffold rods and initial bone formation within the scaffold system. 
In vitro results from Part 1 of our study showed a greater degree of 
physical changes in the NaOH treated scaffolds as compared to the untreated 
group. A significantly large number of 'channel-like' pits and greater average 
pit sizes were detected in the NaOH-treated groups (48 hours treatment; 1 4.51 ± 
10.9 µm) and (96 hours treatment; 20.27 ± 1 4.3 µm). This was clearly absent in 
the untreated group. Untreated PCL-TCP scaffolds reported a high water contact 
angle of 91 .2 ± 8.8°. When treated with NaOH, a greater percentage reduction 
of the water contact angle (40.9- 58.2 %) was reported in the scaffolds, hence an 
improvement in 'wettability'. 
The second part of the study was to investigate the in vivo behavior of 
early matrix deposition and early bone formation of PCL-TCP scaffolds in the 
calvaria of rabbits after 2, 4 and 8 weeks of implantation. NaOH treated scaffolds 
reported greater early matrix deposition and bone formation from scanning 
electron images and microCT analyses. In conclusion, pretreatment of PCL-TCP 
scaffolds with NaOH increases the wettability and surface area for initial matrix 
deposition and early bone ingrowth. 
CHAPTER 6 
The objective of the present study was to investigate the effects of increased 
surface roughness of PCL-TCP scaffolds on the degradation profile, mechanical 
properties and new bone formation in a rabbit calvaria defect model over a period of 
6 months. 3 groups of PCL-TCP scaffolds with varying pretreatment exposures with 
NaOH were studied in a rabbit calvaria defect model and analyzed at 2, 4, 8, 12 and 
24 weeks. (Group A: Untreated, Group B: 3M NaOH/ 48 hours and Group C: 3M 
NaOH/ 96 hours). Mechanical analyses, such as compression and push out testing 
were performed to evaluate the overall strength of the newly regenerated bone 
within the scaffold and the interfacial shear strength at the bone-scaffold interface 
respectively. 
Micro-CT analysis demonstrated that scaffolds with increased surface 
roughness showed a greater impact on the overall volume loss during the early 
healing period between 2 to 8 weeks as compared to the untreated group. In addition, 
1 60 
Summary 
greater bone formation was detected in NaOH treated scaffolds as compared to 
the untreated group throughout the experiment. Scaffolds with increased surface 
roughness generally reported higher push out test and compressive strength values 
between 4 to 8 weeks of early healing. Interestingly, the mechanical properties 
displayed a decline in values from 12 weeks onwards in the modified groups 
suggesting a favourable breakdown or weakening of PCL-TCP scaffolds tailored for 
replacement by new bone formation. Histological analyses over the progressive time 
points revealed increasing amounts of bone and adipose tissue infiltrating the pores 
in all scaffolds without any presence of intense inflammatory reaction. However, 
multinucleated osteoclast-like giant cells were identified in close approximation to 
the surface of the scaffold. The latter suggested that degradation of the PCL-TCP 
scaffolds was taking place. Another interesting result from the histological analyses 
demonstrated an increased volume fraction presence of adipose cell-rich bone 
marrow tissue surrounding the bony trabeculae during the later stages of healing. 
Considerable remodeling of the bone could have occurred and may have assumed a 
more cancellous type characteristic after initial bone healing had taken place. 
CHAPTER 7 
The objective of this chapter was to provide an outline of the progression 
of the studies that were conducted in developing a novel bone substitute targeted 
for ridge augmentation applications. At the beginning, we concluded that the 
rate of bone formation is dependent on the degradation rates of the bone grafting 
materials utilized. Autogenous bone and TCP has been shown to degrade at a faster 
rate allowing the formation of new bone into the defects during the earlier phases 
of healing. In contrast, bone substitutes with limited resorption slowed down the 
amount of new bone formation into the defects. This led to our team's decision to 
incorporate TCP into PCL scaffolds for our subsequent in vitro and in vivo studies. 
Selective modification to further improve the scaffold's performance 
were optimized and later investigated in bone defects of a small animal model. To 
date, we have demonstrated the superior properties and biocompatibility of these 
modified PCL-TCP scaffolds in the calvaria of rabbits. It is of utmost importance 
that prior to testing any novel biomaterial in a pilot human trial, a preclinical animal 
model displaying relevant defects is required to validate the concept. Our team 
has recently completed the study evaluating the use of PCL-TCP scaffolds for the 
reconstruction of localized dentoalveolar defects in a pig model. Preliminary results 
were promising and showed the potential of such modified PCL-TCP scaffolds 
for use in the reconstruction of jaw defects in pigs, however they were still less 
favorable when compared to the autogenous bone grafts. Additional studies have 
been outlined to further improve our novel approach. 
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CONCLUSIONS 
The objective of the thesis focused on the use of PCL-TCP scaffolds 
as bone substitutes tailored for ridge augmentation applications. The series of 
studies have discussed our efforts to develop PCL-TCP scaffolds from 'bench-to­
bedside' as bone substitute constructs. To date, we are currently investigating these 
scaffolds in a large animal model prior to conducting a pilot human study. Clearly, 
our modified PCL-TCP scaffolds alone demonstrated a shortfall when compared 
to the 'Gold Standard' autogenous bone transplants. Additional preclinical studies 
are being outlined to further improve the bone formation capacity of pure PCL­
TCP scaffolds beyond their 60% efficacy when compared to autogenous block 
grafts. The inclusion of cell-based and biologic therapy into tissue engineering 
promote further enhancement of bone formation in large bone defects This has 
led our team to examine the possibility of developing 3rd generation PCL-based 
scaffolds by incorporating biological mediators, growth factors or mesenchymal 
stem cells in them. We hope that in the process of discovering a predictable tissue 
engineered construct, we can proceed to conduct a pilot study to prove that this 
novel technique can replace the current technique of autologous bone grafting 
for the reconstruction of dentoalveolar defects in humans. Our goal is to present 
a viable bone regenerative approach that not only reduces patient morbidity and 




In de introductie wordt de voorspelbaarheid beschreven van tandheelkundige 
implantologie als behandelmodaliteit van deels of volledig tandeloze patienten. 
Bovendien wordt een overzicht gegeven van de beperkingen die men tegenkomt bij 
defecten van de processus alveolaris en het succes van Guided Bone Regeneration 
(GBR) bij de reconstructie van dergelijke defecten. Onderwerpen als het gebruik 
van autoloog, allogeen of xenogeen bot hebben een enorme belangstelling gewekt 
om nieuwe botsubstituten te ontwikkelen die kunnen worden toegepast voor de 
reconstructie van de processus alveolaris. Een lijst met gewenste eigenschappen 
is gedefinieerd waaraan een scaffold zou moeten voldoen. De keuze van ons team 
om PCL scaffolds te selecteren uit een veelheid aan synthetische polymeren, was 
gebaseerd op de superieure mechanische eigenschappen en biocompatibiliteit zoals 
gerapporteerd in eerdere studies. Deze studie werd opgezet om de mogelijkheden te 
onderzoeken van het gebruik van PCL-TCP scaffolds en om deze geschikt te maken 
voor dentoalveolaire toepassingen. 
Hoofdstuk 2 
Het doe! van deze studie was om vier verschillende groepen van 
bottransplantatiematerialen te onderzoeken in gestandaardiseerde botdefecten 
ter plaatse van de angulus mandibulae van 16 minivarkens. De defecten werden 
gerandomiseerd voor de volgende bottransplantatiematerialen. 
Autologe botchips 
Hydroxyapatiet (HA) 
Hydroxyapatiet/ Tricalciumfosfaat (HAffCP; 60%: 40%) 
Tricalciumfosfaat (TCP) 
Histologische en histomorfometrische analyses werden uitgevoerd twee, 
vier, acht en 24 weken postoperatief. Na twee weken genezing bleken autologe 
bottransplantaten de meeste botvorming te genereren in vergelijking met synthetische 
botsubstituten. Na vier en acht weken lieten bot en TCP veel betere botvorming zien 
dan de op hydroxyapatiet gebaseerde bottransplantatiematerialen. Na 24 weken lieten 
alle geteste groepen dezelfde botvorming zien met nauw contact tussen de diverse 
bottransplantatiematerialen en het oorspronkelijke bot. De botgenezingspatronen 
in deze studie suggereren dat de mate van botvorming afhankelijk is van de mate 
van degradatie van de gebruikte bottransplantatiematerialen. Autoloog bot en TCP 
bleken sneller te degraderen waardoor de vorming van nieuw bot in de defecten 
gedurende de vroege fase van genezing mogelijk bleek. De beperkte mate van 
resorptie op HA gebaseerde botsubstituten daarentegen werkten vertragend op de 




Deze tudie werd uitgevoerd om de degradatiekarakteristiek en de fysische 
eigenschappen van PCL-TCP scaffolds te onderzoeken die waren ondergedompeld 
in een standaard kweekmedium onder fysiologische condities gedurende 24 weken. 
Tevens werd het in vivo degradatiegedrag van PCL-TCP scaffolds onderzocht na 
implantatie in de buik van ratten gedurende 24 weken. Veranderingen in moleculair 
gewicht, porositeit, mechanische eigenschappen en oppervlakte eigenschappen 
werden bekeken. 
De in vitro en in vivo degradatie van PCL-TCP scaffolds bleek verschillend 
in de loop van de 24 weken. De mate van degradatie van PCL-TCP scaffolds in vivo 
was grater dan die in vitro. De scaffolds degradeerden over het algemeen sneller na 
implantatie in de buik van ratten. Na 24 weken bleek de toename van de gemiddelde 
porositeit van de scaffolds in vivo significant grater dan in vitro. De PCL-TCP 
scaffolds die in deze studie werden gebruikt, behielden hun onderling verbonden 
poriestructuur met de toename van meer porositeit. Dit is ideaal, omdat het een 
uitgebreidere vascularisatie stimuleert door de scaffold heen. GPC analyses lieten 
eenzelfde trend zien waarbij een significante afname van de MN en Mw waarden werd gezien in vivo in vergelijking met die in vitro na 24 weken. 
Hoofdstuk 4 
Oppervlakte-aanpassingen van de PCL-TCP scaffolds werden Iangs 
chemische en enzymatische weg uitgevoerd met in stand houden van gunstige 
oppervlakte- en fysische eigenschappen. Deze studie had tot doe! de in vitro 
degradatie van scaffolds te vervolgen in of een 3M natrium hydroxide (NaOH) 
dan we! in een 0, I %  lipase oplossing gedurende 108 uren. Een grotere mate van 
degradatie en afname van fysische eigenschappen van de scaffolds werd gezien in 
de lipase behandelde scaffolds ten opzichte van de NaOH behandelde scaffolds. 
Toename van gewichtsverlies en gemiddelde porositeit van de scaffolds werd gemeten 
in de lipase behandelde groep ter waarde van 90,6% en 22,9% respectievelijk in 
vergelijking met 52,8% en 11,8% in de NaOH behandelde groep aan het einde van 
het experiment. Mechanische testen lieten eenzelfde trend zien met volledig verlies 
van compressiesterkte en modulus al na 60 uren in de lipase behandelde groep. 
Samenvattend liet deze studie zien dat selectieve modificatie van met behulp van 
NaOH geproduceerde PCL-TCP scaffolds met toegenomen oppervlakte ruwheid 
zich manifesteerde als microporeuze inkepingen. Dit Ievert een veelbelovende 
oppervlakte topografie op om botvorming te Iaten optreden in vergelijking met de 
lipase behandelde groep. Voorbehandeling met NaOH is een eenvoudige benadering 
om de fysische eigenschappen en de degradatie van PCL-TCP scaffolds te reguleren 
die mogelijk zouden kunnen worden gebruikt als biomaterialen voor botregeneratie 
procedures van de processus alveolaris. 
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Hoofdstuk 5 
Deze studie had tot doel de PCL-TCP scaffolds te modificeren door 
voorbehandeling met NaOH met de bedoeling de oppervlaktekarakteristieken van 
de scaffolds te veranderen. In het in vitro gedeelte concentreerde de studie zich op de 
veranderingen van oppervlaktekarakteristieken, hydrofiliciteit, porie morphologie 
en structurele architectuur van de PCL-TCP scaffolds na behandeling met NaOH 
op verschillende tijdsintervallen (0, 48 en 96 uur). In het in vivo gedeelte lag de 
nadruk op de analyse van vroege afzetting van matrix en cellen op de scaffolds 
en beginnende botvorming in het scaffold systeem. In vitro resultaten van dee) 
I van deze studie lieten een grotere mate van fysische veranderingen zien in de 
NaOH behandelde scaffolds in vergelijking met de niet behandelde groep. Een 
significant groter aantal kanaalachtige indeukingen met gemiddeld grotere diepte 
werd ontdekt in de NaOH behandelde groepen (48 uren behandeling; 14,5 1 ± 10,9 
µm) en (96 uren behandeling; 20,27 ± 14,3 µm). Dit was duidelijk niet aanwezig 
in de niet behandelde groep. Niet behandelde PCL-TCP scaffolds lieten een grotere 
watercontacthoek van 9 1,2 ± 8,8°zien. Na behandeling met NaOH werd een reductie 
van de watercontacthoek (40,9 - 58,2%) gezien in de scaffolds wat duidt op een 
verbetering van de bevochtigbaarheid. In het tweede gedeelte van de studie werd 
het in vivo gedrag van vroege matrixafzetting en vroege botvorming van PCL-TCP 
scaffolds in de schedels van konijnen onderzocht na respectievelijk 2, 4 en 8 weken 
na implantatie. NaOH behandelde scaffolds lieten meer vroege matrixafzetting 
en botvorming zien bij scanning electronen microscopie en microCT analyses. 
Geconcludeerd kan worden dat voorbehandeling van PCL-TCP scaffolds met NaOH 
de bevochtigbaarheid doet toenemen alsmede het oppervlak vergroot ten gunste van 
initiele matrixafzetting en vroege botingroei. 
Hoofdstuk 6 
Het doe) van deze studie was om het effect te onderzoeken van toegenomen 
oppervlakteruwheid van PCL-TCP scaffolds op het degradatiegedrag, mechanische 
eigenschappen en nieuwe botvorming in een konijnenschedel defectmodel gedurende 
een periode van zes maanden. Orie groepen van CL-TCP scaffolds met verschillende 
voorbehandelingen met NaOH werden bestudeerd in het konijnenschedel 
defectmodel en geanalyseerd na 2, 4, 8, 12 en 24 weken. (Groep A: onbehandeld, 
groep B: 3M NaOH/48 uur en groep C: 3M NaOH/96 uur). Mechanische analyses 
als compressie- en uitdruktesten werden uitgevoerd om de sterkte van het nieuw 
ontstane bot in de scaffolds te evalueren alsmede de afschuifsterkte op het 
overgangsgebied tussen bot en scaffold. Micro-CT analyse liet zien dat scaffolds met 
toegenomen oppervlakteruwheid een groter effect bleken te hebben op het algehele 
volumeverlies gedurende de vroege genezingsperiode tussen twee tot acht weken 
in vergelijking met de niet behandelde groep. Bovendien werd meer botvorming 
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ontdekt in de NaOH behandelde scaffolds in vergelijking met de onbehandelde groep 
gedurende het gehele experiment. Scaffolds met toegenomen oppervlakte ruwheid 
lieten hogere waarden zien voor de uitdruktest en compressiesterkte tussen vier tot 
acht weken na genezing. Belangwekkend is dat de mechanische eigenschappen 
afnemende waarden lieten zien na 12 weken en later in de gemodificeerde groepen. 
Dit suggereert een gunstige atbraak of verzwakking van PCL-TCP scaffolds die 
geschikt gemaakt zijn voor vervanging door nieuw bot. Histologische analyses op 
oplopende tijdsintervallen liet toenemende hoeveelheden van bot en vetweefsel 
zien die ingroeiden in de porien in alle scaffolds zonder enige aanwezigheid van 
een duidelijke ontstekingsreactie. Echter, meerkemige, osteoclastische reuscellen 
werden gei'dentificeerd in dichte nabijheid van het oppervlakte van de scaffold. 
Dit laatste suggereert dat degradatie van de PCL-TCP scaffolds plaatsvond. Een 
ander belangwekkend resultaat van de histologische analyses was een toegenomen 
aanwezigheid van vettig celrijk beenmerg rond de benige trabeculae gedurende 
de latere fasen van genezing. Aanzienlijke ombouw van bot zou hebben kunnen 
plaatsvinden wat een meer spongieus type bot zou hebben mogen opleveren nadat 
initiele botgenezing had plaatsgevonden. 
Hoofdstuk 7 
Doe) van dit artikel was om een overzicht te geven van de voortgang die 
werd geboekt met resultaten van de studies die werden uitgevoerd om een nieuw 
botsubstituut teontwikkelen bedoeld voor toepassing in de process us alveolaris. In het 
begin concludeerden wij dat de mate van botvorming afhankelijk is van de degradatie 
karakteristieken van de gebruikte bottransplantatiematerialen. Autoloog bot en TCP 
bleken sneller te degraderen waardoor de vorming van nieuwe bot in de defecten 
gedurende de vroege fase van genezing werd mogelijk gemaakt. Botsubstituten met 
een beperkte resorptie daarentegen vertraagden de mate van nieuwe botvorming in 
de defecten. Daarom besliste ons team om TCP te incorporeren in PCL scaffolds 
ten behoeve van onze volgende in vitro en in vivo studies. Specifieke aanpassingen 
werden gedaan om het gedrag van de scaffolds verder te verbeteren. Dit werd later 
onderzocht in botdefecten van kleine dieren. Wij konden de superieure eigenschappen 
en biocompatibiliteit aantonen van deze gemodificeerde PCL-TCP scaffolds in de 
schedels van konijnen. Het is van wezenlijk belang dat, voordat welke biomateriaal 
dan ook in een humane pilotstudie wordt getest, eerst relevante defecten in een 
preklinisch diermodel worden onderzocht om een nieuw concept te testen. Recent 
heeft ons team een studie voltooid waarin het gebruik van PCL-TCP scaffolds voor 
de reconstructie van locale defecten in de processus alveolaris in een varkensmodel 
werd getest. Helaas leveren PCL-TCP scaffolds een minder goed resultaat op in 
vergelijking met autologe bottransplantaten. Aanvullende studies zijn opgezet om 
onze nieuwe benadering verder te verbeteren. 
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Het doel van dit proefschrift was het gebruik te onderzoeken van PCL-TCP 
scaffolds als botsubstituten, geschikt voor toepassing in de processus alveolaris. 
In deze studieserie werden onze pogingen beschreven om PCL-TCP scaffolds 
te ontwikkelen als botsubstituutsysteem vanaf idee tot klinische toepassing. 
Momenteel worden deze scaffolds onderzocht in een groot proefdiermodel dat 
moet leiden tot een humane pilotstudie. Het is duidelijk  dat onze gemodificeerde 
PCL-TCP scaffolds op zich een tekortkoming Iieten zien in vergelijking met 
autologe bottransplantaten als gouden standaard. Aanvullende preklinische studies 
zijn opgezet om de botvormingscapaciteit van zuivere PCL-TCP scaffolds te 
verbeteren tot een werkzaamheid van meer dan 60% in vergelijking met autologe 
bloktransplantaten. Het combineren van cytologische en biologische therapie en 
tissue engineering heeft een gunstige invloed op de botvorming in grote botdefecten. 
Dit heeft ons team ertoe gebracht de mogelijkheid te onderzoeken een derde generatie 
op PCL-gebaseerde scaffolds te ontwikkelen waarin biologische mediatoren, 
groeifactoren of mesenchymale stamcellen zijn gei'ncorporeerd. Wij hopen dat 
wij ergens in het ontwikkelingsproces van een voorspelbaar tissue engineered 
product zoveel voortgang kunnen boeken dat wij een humane pilotstudie kunnen 
gaan uitvoeren om te bewijzen dat deze nieuwe techniek de huidige techniek van 
autologe bottransplantatie kan vervangen voor de reconstructie van dentoalveolaire 
defecten. Ons doe) is een levensvatbare botregeneratiebenadering te presenteren die 
niet alleen morbiditeit en ongemak voor de patient reduceert, maar ook betaalbaar, 
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